BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fitzgerald RC, Hardwick R, Huntsman D, Carneiro F, Guilford P, Blair V, Chung DC, Norton J, Ragunath K, Van Krieken JH, Dwerryhouse S, Caldas C;  International Gastric Cancer Linkage Consortium. Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J Med Genet. 2010;47:436-444. [PMID: 20591882 DOI: 10.1136/jmg.2009.074237] [Cited by in Crossref: 380] [Cited by in F6Publishing: 411] [Article Influence: 29.2] [Reference Citation Analysis]
Number Citing Articles
1 Muranaka F, Kise E, Tokumaru S, Kitazawa M, Miyagawa Y, Suga T, Uehara T, Iwaya M, Kobayashi S, Sato M, Gomi D, Yamada H, Sugimura H, Kosho T, Soejima Y, Koizumi T. Hereditary diffuse gastric cancer in a Japanese family with CDH1 mutation three case reports. Discov Oncol 2023;14:14. [PMID: 36719602 DOI: 10.1007/s12672-023-00623-4] [Reference Citation Analysis]
2 Abele M, Grabner L, Blessing T, Block A, Agaimy A, Kratz C, Simon T, Calaminus G, Heine S, Corbacioglu S, Christiansen H, Schneider DT, Brecht IB. Epidemiology and Characteristics of Gastric Carcinoma in Childhood-An Analysis of Data from Population-Based and Clinical Cancer Registries. Cancers (Basel) 2023;15. [PMID: 36612313 DOI: 10.3390/cancers15010317] [Reference Citation Analysis]
3 Garcia-Pelaez J, Barbosa-Matos R, Lobo S, Dias A, Garrido L, Castedo S, Sousa S, Pinheiro H, Sousa L, Monteiro R, Maqueda JJ, Fernandes S, Carneiro F, Pinto N, Lemos C, Pinto C, Teixeira MR, Aretz S, Bajalica-Lagercrantz S, Balmaña J, Blatnik A, Benusiglio PR, Blanluet M, Bours V, Brems H, Brunet J, Calistri D, Capellá G, Carrera S, Colas C, Dahan K, de Putter R, Desseignés C, Domínguez-Garrido E, Egas C, Evans DG, Feret D, Fewings E, Fitzgerald RC, Coulet F, Garcia-Barcina M, Genuardi M, Golmard L, Hackmann K, Hanson H, Holinski-Feder E, Hüneburg R, Krajc M, Lagerstedt-Robinson K, Lázaro C, Ligtenberg MJL, Martínez-Bouzas C, Merino S, Michils G, Novaković S, Patiño-García A, Ranzani GN, Schröck E, Silva I, Silveira C, Soto JL, Spier I, Steinke-Lange V, Tedaldi G, Tejada MI, Woodward ER, Tischkowitz M, Hoogerbrugge N, Oliveira C. Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes. Lancet Oncol 2023;24:91-106. [PMID: 36436516 DOI: 10.1016/S1470-2045(22)00643-X] [Reference Citation Analysis]
4 Kole C, Charalampakis N, Sakellariou S, Papaxoinis G, Apostolou KG, Machairas N, Papanikolaou IS, Schizas D. Hereditary Diffuse Gastric Cancer: A 2022 Update. J Pers Med 2022;12. [PMID: 36556253 DOI: 10.3390/jpm12122032] [Reference Citation Analysis]
5 Liu ZX, Zhang XL, Zhao Q, Chen Y, Sheng H, He CY, Sun YT, Lai MY, Wu MQ, Zuo ZX, Wang W, Zhou ZW, Wang FH, Li YH, Xu RH, Qiu MZ. Whole-Exome Sequencing Among Chinese Patients With Hereditary Diffuse Gastric Cancer. JAMA Netw Open 2022;5:e2245836. [PMID: 36484990 DOI: 10.1001/jamanetworkopen.2022.45836] [Reference Citation Analysis]
6 Muranaka F, Kise E, Tokumaru S, Kitazawa M, Miyagawa Y, Suga T, Uehara T, Iwaya M, Kobayashi S, Sato M, Gomi D, Yamada H, Sugimura H, Kosho T, Soejima Y, Koizumi T. Hereditary Diffuse Gastric Cancer in a Japanese Family with CDH1 Mutation: Three Individuals Undergoing Total Gastrectomy Following Presymptomatic Genomic Diagnosis.. [DOI: 10.21203/rs.3.rs-2232044/v1] [Reference Citation Analysis]
7 Stanich PP, Elgindi D, Stoffel E, Koeppe E, Bansal A, Stetson R, Collins DL, Clark DF, Karloski E, Dudley B, Brand RE, Hall MJ, Chertock Y, Sullivan BA, Muller C, Hinton A, Katona BW, Kupfer SS. Colorectal Neoplasia in CDH1 Pathogenic Variant Carriers: A Multicenter Analysis. Am J Gastroenterol 2022;117:1877-9. [PMID: 36087100 DOI: 10.14309/ajg.0000000000001996] [Reference Citation Analysis]
8 Yan Q, Wu Y, Li D, Li Y, Stefan-van Staden R. A-Kinase Anchoring Protein 9 Promotes Gastric Cancer Progression as a Downstream Effector of Cadherin 1. Journal of Oncology 2022;2022:1-7. [DOI: 10.1155/2022/2830634] [Reference Citation Analysis]
9 Bluebond R, Bannon SA, Hyde SM, Woodson AH, You NY, Lu KH, Arun B. Hereditary Cancer Syndromes: Risk Assessment and Genetic Counseling. Holland‐Frei Cancer Medicine 2022. [DOI: 10.1002/9781119000822.hfcm143.pub2] [Reference Citation Analysis]
10 Long JM, Ebrahimzadeh J, Stanich PP, Katona BW. Endoscopic Surveillance in Patients with the Highest Risk of Gastric Cancer: Challenges and Solutions. Cancer Manag Res 2022;14:2953-69. [PMID: 36238953 DOI: 10.2147/CMAR.S277898] [Reference Citation Analysis]
11 Guo Y, Wang Q, Tian Q, Bo C, Li N, Zhang S, Li P, Huang T. Clinicopathological Features and Prognostic-Related Risk Factors of Gastric Signet Ring Cell Carcinoma: A Meta-Analysis. Computational and Mathematical Methods in Medicine 2022;2022:1-11. [DOI: 10.1155/2022/3473445] [Reference Citation Analysis]
12 Kabbage M, Ben Aissa-haj J, Othman H, Jaballah-gabteni A, Laarayedh S, Elouej S, Medhioub M, Kettiti HT, Khsiba A, Mahmoudi M, Belfekih H, Maaloul A, Touinsi H, Hamzaoui L, Chelbi E, Abdelhak S, Boubaker MS, Azzouz MM. A Rare MSH2 Variant as a Candidate Marker for Lynch Syndrome II Screening in Tunisia: A Case of Diffuse Gastric Carcinoma. Genes 2022;13:1355. [DOI: 10.3390/genes13081355] [Reference Citation Analysis]
13 Cosma LS, Schlosser S, Tews HC, Müller M, Kandulski A. Hereditary Diffuse Gastric Cancer: Molecular Genetics, Biological Mechanisms and Current Therapeutic Approaches. Int J Mol Sci 2022;23:7821. [PMID: 35887173 DOI: 10.3390/ijms23147821] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Carneiro F. Familial and hereditary gastric cancer, an overview. Best Pract Res Clin Gastroenterol 2022;58-59:101800. [PMID: 35988963 DOI: 10.1016/j.bpg.2022.101800] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Ruf B, Roggia C, Schroeder C, Mattern S, Fend F, Klag T, Götz M. Chromoendoscopy in Combination with Random Biopsies for Patients with Pathogenic CDH1 Mutations Undergoing Endoscopic Surveillance. J Gastrointest Canc. [DOI: 10.1007/s12029-022-00831-1] [Reference Citation Analysis]
16 Ivey A, Pratt H, Boone BA. Molecular pathogenesis and emerging targets of gastric adenocarcinoma. J Surg Oncol 2022;125:1079-95. [PMID: 35481910 DOI: 10.1002/jso.26874] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Zhang J, Bai J, Zhu H, Li W, An Q, Wang D. The upregulation of circFNDC3B aggravates the recurrence after endoscopic submucosal dissection (ESD) in early gastric cancer (EGC) patients. Sci Rep 2022;12:6178. [PMID: 35418175 DOI: 10.1038/s41598-022-07154-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Treese C, Siegmund B, Daum S. Hereditary Diffuse Gastric Cancer—Update Based on the Current Consort Recommendations. Current Oncology 2022;29:2454-60. [DOI: 10.3390/curroncol29040199] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
19 Lerner BA, Xicola RM, Rodriguez NJ, Karam R, Llor X. Simplified and more sensitive criteria for identifying individuals with pathogenic CDH1 variants. J Med Genet 2023;60:36-40. [PMID: 35078942 DOI: 10.1136/jmedgenet-2021-108169] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Corso G, Magnoni F, Trovato C, Girardi A, Seruca R, Figueiredo J, Roviello F. Hereditary Gastric Cancer: A New Syndrome. Gastric Cancer: the 25-year R-Evolution 2022. [DOI: 10.1007/978-3-030-73158-8_5] [Reference Citation Analysis]
21 Vaiphei K. Helicobacter pylori Negative Gastric Cancer. Interpretation of Endoscopic Biopsy - Gastritis, Gastropathies and Beyond 2022. [DOI: 10.1007/978-981-16-6026-9_16] [Reference Citation Analysis]
22 Garcia-Pelaez J, Barbosa-Matos R, São José C, Sousa S, Gullo I, Hoogerbrugge N, Carneiro F, Oliveira C. Gastric cancer genetic predisposition and clinical presentations: Established heritable causes and potential candidate genes. Eur J Med Genet 2022;65:104401. [PMID: 34871783 DOI: 10.1016/j.ejmg.2021.104401] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
23 Hallowell N, Badger S, Lawton J. Eating to live or living to eat: The meaning of hunger following gastric surgery. SSM - Qualitative Research in Health 2021;1:100005. [DOI: 10.1016/j.ssmqr.2021.100005] [Reference Citation Analysis]
24 Li M, Rao X, Cui Y, Zhang L, Li X, Wang B, Zheng Y, Teng L, Zhou T, Zhuo W. The keratin 17/YAP/IL6 axis contributes to E-cadherin loss and aggressiveness of diffuse gastric cancer. Oncogene 2021. [PMID: 34845376 DOI: 10.1038/s41388-021-02119-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
25 Luu MN, Quach DT, Hiyama T. Screening and surveillance for gastric cancer: Does family history play an important role in shaping our strategy? Asia Pac J Clin Oncol 2021. [PMID: 34811928 DOI: 10.1111/ajco.13704] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Gamble LA, Davis JL. Surveillance and Surgical Considerations in Hereditary Diffuse Gastric Cancer. Gastrointest Endosc Clin N Am 2022;32:163-75. [PMID: 34798984 DOI: 10.1016/j.giec.2021.08.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Taja-Chayeb L, Vidal-Millán S, Trejo-Becerril C, Pérez-Cárdenas E, Chávez-Blanco A, Domínguez-Gómez G, González-Fierro A, Romo-Pérez A, Dueñas-González A. Hereditary Diffuse Gastric Cancer (HDGC). An overview. Clin Res Hepatol Gastroenterol 2021;:101820. [PMID: 34656755 DOI: 10.1016/j.clinre.2021.101820] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Pan Z, Fu Z, Luo C, Bao Y, Wang M, Cao W, Xu X. CDH1 germline mutations in a Chinese cohort with hereditary diffuse gastric cancer. J Cancer Res Clin Oncol 2021. [PMID: 34537906 DOI: 10.1007/s00432-021-03775-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Barbosa-Matos R, Leal Silva R, Garrido L, Aguiar AC, Garcia-Pelaez J, André A, Seixas S, Sousa SP, Ferro L, Vilarinho L, Gullo I, Devezas V, Oliveira R, Fernandes S, Costa SC, Magalhães A, Baptista M, Carneiro F, Pinheiro H, Castedo S, Oliveira C. The CDH1 c.1901C>T Variant: A Founder Variant in the Portuguese Population with Severe Impact in mRNA Splicing. Cancers (Basel) 2021;13:4464. [PMID: 34503274 DOI: 10.3390/cancers13174464] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
30 Lobo S, Benusiglio PR, Coulet F, Boussemart L, Golmard L, Spier I, Hüneburg R, Aretz S, Colas C, Oliveira C. Cancer predisposition and germline CTNNA1 variants. Eur J Med Genet 2021;64:104316. [PMID: 34425242 DOI: 10.1016/j.ejmg.2021.104316] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
31 Maccaroni E, Giampieri R, Lenci E, Scortichini L, Bianchi F, Belvederesi L, Brugiati C, Pagliaretta S, Ambrosini E, Berardi R. BRCA mutations and gastrointestinal cancers: When to expect the unexpected? World J Clin Oncol 2021; 12(7): 565-580 [PMID: 34367929 DOI: 10.5306/wjco.v12.i7.565] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
32 Furth EE. Grossing of Gastrointestinal Specimens: Best Practices and Current Controversies. Surg Pathol Clin 2020;13:359-70. [PMID: 32773188 DOI: 10.1016/j.path.2020.04.001] [Reference Citation Analysis]
33 Zhao S, Lv L, Zheng K, Tian Y, Zheng JC, Jiang CG. Prognosis and Biological Behavior of Gastric Signet-Ring Cell Carcinoma Better or Worse: A Meta-Analysis. Front Oncol 2021;11:603070. [PMID: 34277391 DOI: 10.3389/fonc.2021.603070] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
34 Faiskhanova RR, Sakaeva DD. Clinical case of gastric cancer in patient with hereditary BRCA-associated ovarian cancer. Medicinskij alfavit 2021. [DOI: 10.33667/2078-5631-2021-10-35-38] [Reference Citation Analysis]
35 Ithurralde-Argerich J, Rosner L, Rizzolo M, Faerberg A, Puma R, Ferro D, Duque C, Kujaruk M, Cuenca-Abente F. Laparoscopic Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer in CDH1 Mutation Carriers. J Laparoendosc Adv Surg Tech A 2021;31:729-37. [PMID: 34097461 DOI: 10.1089/lap.2021.0239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Rustgi SD, Ching CK, Kastrinos F. Inherited Predisposition to Gastric Cancer. Gastrointest Endosc Clin N Am 2021;31:467-87. [PMID: 34053634 DOI: 10.1016/j.giec.2021.03.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
37 Benesch MGK, Bursey SR, O'Connell AC, Ryan MG, Howard CL, Stockley CC, Mathieson A. CDH1 Gene Mutation Hereditary Diffuse Gastric Cancer Outcomes: Analysis of a Large Cohort, Systematic Review of Endoscopic Surveillance, and Secondary Cancer Risk Postulation. Cancers (Basel) 2021;13:2622. [PMID: 34073553 DOI: 10.3390/cancers13112622] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
38 Dang DNT, Nguyen HTT, Ngo HD, Tran BM, Vu AD, Dang HQ, Ta VT. A novel stop codon mutation in exon 5 (c.639G>A) of the cadherin-1 gene in a Vietnamese man with hereditary diffuse gastric cancer: a case report. J Med Case Rep 2021;15:263. [PMID: 33941229 DOI: 10.1186/s13256-021-02837-y] [Reference Citation Analysis]
39 Schueler SA, Gamble LA, Curtin BF, Ruff SM, Connolly M, Hannah C, Quezado M, Miettinen M, George M, Blakely AM, Hernandez JM, Heller T, Koh C, Davis JL. Evaluation of confocal laser endomicroscopy for detection of occult gastric carcinoma in CDH1 variant carriers. J Gastrointest Oncol 2021;12:216-25. [PMID: 34012620 DOI: 10.21037/jgo-20-430] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
40 Woodward ER, van Veen EM, Evans DG. From BRCA1 to Polygenic Risk Scores: Mutation-Associated Risks in Breast Cancer-Related Genes. Breast Care (Basel) 2021;16:202-13. [PMID: 34248461 DOI: 10.1159/000515319] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
41 Lerner BA, Llor X. Genetic Gastric Cancer Risk Syndromes. Curr Treat Options Gastroenterol 2020;18:604-15. [PMID: 33776403 DOI: 10.1007/s11938-020-00312-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
42 Fornaro L, Spallanzani A, de Vita F, D'Ugo D, Falcone A, Lorenzon L, Tirino G, Cascinu S; GAIN (GAstric Cancer Italian Network). Beyond the Guidelines: The Grey Zones of the Management of Gastric Cancer. Consensus Statements from the Gastric Cancer Italian Network (GAIN). Cancers (Basel) 2021;13:1304. [PMID: 33804024 DOI: 10.3390/cancers13061304] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 Pappas A, Tan WK, Waldock W, Richardson S, Tripathi M, Januszewicz W, Roberts G, O'Donovan M, Fitzgerald RC, di Pietro M. Single-bite versus double-bite technique for mapping biopsies during endoscopic surveillance for hereditary diffuse gastric cancer: a single-center, randomized trial. Endoscopy 2021;53:246-53. [PMID: 32679601 DOI: 10.1055/a-1201-3125] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Namikawa K, Kawachi H, Tsugeno Y, Nakajima T, Fujisaki J. Detection of multiple intramucosal signet-ring cell carcinomas by white-light endoscopy and magnifying endoscopy with narrow-band imaging in a hereditary diffuse gastric cancer patient with a CDH1 germline mutation. VideoGIE 2021;6:163-6. [PMID: 33898891 DOI: 10.1016/j.vgie.2020.11.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
45 Dilek FH, Kahraman DİA. Histopathological Findings in Prophylactic Surgical Specimens. Prophylactic Surgery 2021. [DOI: 10.1007/978-3-030-66853-2_26] [Reference Citation Analysis]
46 Malli IA. From Inflammation to Cancer: Role of Genetic Polymorphisms of Inflammatory Pathway Molecules in Gastric Cancer. Genetic Polymorphism and cancer susceptibility 2021. [DOI: 10.1007/978-981-33-6699-2_4] [Reference Citation Analysis]
47 Dilek ON. Prophylactic Surgery: Why, When, and How? Prophylactic Surgery 2021. [DOI: 10.1007/978-3-030-66853-2_1] [Reference Citation Analysis]
48 Özsoy M, Yaylak F. Stomach and Duodenum Resections for Genetic Predispositions. Prophylactic Surgery 2021. [DOI: 10.1007/978-3-030-66853-2_14] [Reference Citation Analysis]
49 Gullo I, Oliveira C, van der Post RS, van Dieren JM, Davis JL, Bougen-zhukov N, Guilford P, Carneiro F. Updated perspective and directions on hereditary diffuse gastric cancer. Research and Clinical Applications of Targeting Gastric Neoplasms 2021. [DOI: 10.1016/b978-0-323-85563-1.00011-3] [Reference Citation Analysis]
50 Cubiella J, Pérez Aisa Á, Cuatrecasas M, Díez Redondo P, Fernández Esparrach G, Marín-gabriel JC, Moreira L, Núñez H, Pardo López ML, Rodríguez de Santiago E, Rosón P, Sanz Anquela JM, Calvet X. Gastric cancer screening in low incidence populations: Position statement of AEG, SEED and SEAP. Gastroenterología y Hepatología (English Edition) 2021;44:67-86. [DOI: 10.1016/j.gastre.2020.08.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
51 Gullo I, van der Post RS, Carneiro F. Recent advances in the pathology of heritable gastric cancer syndromes. Histopathology 2021;78:125-47. [PMID: 33382491 DOI: 10.1111/his.14228] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
52 Marwitz T, Hüneburg R, Spier I, Lau JF, Kristiansen G, Lingohr P, Kalff JC, Aretz S, Nattermann J, Strassburg CP. Hereditary Diffuse Gastric Cancer: A Comparative Cohort Study According to Pathogenic Variant Status. Cancers (Basel) 2020;12:E3726. [PMID: 33322525 DOI: 10.3390/cancers12123726] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
53 Tang CT, Chen Y, Zeng C. Prognostic analysis of gastric signet ring cell carcinoma and mucinous carcinoma: a propensity score-matched study and competing risk analysis. Aging (Albany NY) 2020;12:22059-77. [PMID: 33130635 DOI: 10.18632/aging.104048] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
54 El Rami FE, Barsoumian HB, Khneizer GW. Hereditary diffuse gastric cancer therapeutic roadmap: current and novel approaches in a nutshell. Ther Adv Med Oncol 2020;12:1758835920967238. [PMID: 33193828 DOI: 10.1177/1758835920967238] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
55 Djanani A. Familiäre gastrointestinale Tumorerkrankungen: daran denken! J Gastroenterol Hepatol Erkr 2020;18:95-101. [DOI: 10.1007/s41971-020-00085-3] [Reference Citation Analysis]
56 Cubiella J, Pérez Aisa Á, Cuatrecasas M, Díez Redondo P, Fernández Esparrach G, Marín-Gabriel JC, Moreira L, Núñez H, Pardo López ML, Rodríguez de Santiago E, Rosón P, Sanz Anquela JM, Calvet X; en representación de la Asociación Española de Gastroenterología, la Sociedad Española de Endoscopia Digestiva y la Sociedad Española de Anatomía Patológica. Gastric cancer screening in low incidence populations: Position statement of AEG, SEED and SEAP. Gastroenterol Hepatol 2021;44:67-86. [PMID: 33252332 DOI: 10.1016/j.gastrohep.2020.08.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
57 Tsugeno Y, Nakano K, Nakajima T, Namikawa K, Takamatsu M, Yamamoto N, Fujisaki J, Nunobe S, Kitagawa M, Takeuchi K, Kawachi H. Histopathologic Analysis of Signet-ring Cell Carcinoma In Situ in Patients With Hereditary Diffuse Gastric Cancer. Am J Surg Pathol 2020;44:1204-12. [PMID: 32520759 DOI: 10.1097/PAS.0000000000001511] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
58 Iyer P, Moslim M, Farma JM, Denlinger CS. Diffuse gastric cancer: histologic, molecular, and genetic basis of disease. Transl Gastroenterol Hepatol 2020;5:52. [PMID: 33073047 DOI: 10.21037/tgh.2020.01.02] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
59 Schumacher J. Genetik des Magenkarzinoms. Onkologe 2020;26:918-926. [DOI: 10.1007/s00761-020-00806-6] [Reference Citation Analysis]
60 van Dieren JM, Kodach LL, den Hartog P, van der Kolk LE, Sikorska K, van Velthuysen MF, van Sandick JW, Koemans WJ, Snaebjornsson P, Cats A. Gastroscopic surveillance with targeted biopsies compared with random biopsies in CDH1 mutation carriers. Endoscopy 2020;52:839-46. [PMID: 32408363 DOI: 10.1055/a-1157-8678] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
61 Goud HK, Mehkari Z, Mohammed L, Javed M, Althwanay A, Ahsan F, Oliveri F, Rutkofsky IH. Significance of E-cadherin Gene Mutations in Patients With Hereditary Diffuse Gastric Cancer Syndrome: A Systematic Review. Cureus 2020;12:e10406. [PMID: 33062523 DOI: 10.7759/cureus.10406] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
62 Martínez Valenzuela C, Castelán-Maldonado EE, Carvajal-Zarrabal O, Calderón-Garcidueñas AL. First report of a Mexican family with mutation in the CDH1 gene. Mol Genet Genomic Med 2020;8:e1208. [PMID: 32886433 DOI: 10.1002/mgg3.1208] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
63 Blair VR, McLeod M, Carneiro F, Coit DG, D'Addario JL, van Dieren JM, Harris KL, Hoogerbrugge N, Oliveira C, van der Post RS, Arnold J, Benusiglio PR, Bisseling TM, Boussioutas A, Cats A, Charlton A, Schreiber KEC, Davis JL, Pietro MD, Fitzgerald RC, Ford JM, Gamet K, Gullo I, Hardwick RH, Huntsman DG, Kaurah P, Kupfer SS, Latchford A, Mansfield PF, Nakajima T, Parry S, Rossaak J, Sugimura H, Svrcek M, Tischkowitz M, Ushijima T, Yamada H, Yang HK, Claydon A, Figueiredo J, Paringatai K, Seruca R, Bougen-Zhukov N, Brew T, Busija S, Carneiro P, DeGregorio L, Fisher H, Gardner E, Godwin TD, Holm KN, Humar B, Lintott CJ, Monroe EC, Muller MD, Norero E, Nouri Y, Paredes J, Sanches JM, Schulpen E, Ribeiro AS, Sporle A, Whitworth J, Zhang L, Reeve AE, Guilford P. Hereditary diffuse gastric cancer: updated clinical practice guidelines. Lancet Oncol 2020;21:e386-97. [PMID: 32758476 DOI: 10.1016/S1470-2045(20)30219-9] [Cited by in Crossref: 109] [Cited by in F6Publishing: 91] [Article Influence: 36.3] [Reference Citation Analysis]
64 Hu MN, Hu SH, Zhang XW, Xiong SM, Deng H. Overview on new progress of hereditary diffuse gastric cancer with CDH1 variants. Tumori 2020;106:346-55. [PMID: 32811340 DOI: 10.1177/0300891620949668] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
65 Devezas V, Baptista M, Gullo I, Rocha J, Sousa F, Xiaogang W, Preto J, Costa S, Castedo S, Garrido L, Oliveira C, Barbosa E, Carneiro F, Barbosa J. Risk-reducing total gastrectomy in asymptomatic CDH1 carriers. Eur Surg 2020;52:171-178. [DOI: 10.1007/s10353-020-00630-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
66 Peleg Hasson S, Menes T, Sonnenblick A. Comparison of Patient Susceptibility Genes Across Breast Cancer: Implications for Prognosis and Therapeutic Outcomes. Pharmgenomics Pers Med 2020;13:227-38. [PMID: 32801835 DOI: 10.2147/PGPM.S233485] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
67 Choi YJ, Ohn JH, Kim N, Kim W, Park K, Won S, Sael L, Shin CM, Lee SM, Lee S, An HJ, Jang DM, Han BW, Lee HS, Kang SJ, Kim JS, Lee DH. Family-based exome sequencing combined with linkage analyses identifies rare susceptibility variants of MUC4 for gastric cancer. PLoS One 2020;15:e0236197. [PMID: 32701958 DOI: 10.1371/journal.pone.0236197] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
68 Lyons K, Le LC, Pham YT, Borron C, Park JY, Tran CTD, Tran TV, Tran HT, Vu KT, Do CD, Pelucchi C, La Vecchia C, Zgibor J, Boffetta P, Luu HN. Gastric cancer: epidemiology, biology, and prevention: a mini review. Eur J Cancer Prev. 2019;28:397-412. [PMID: 31386635 DOI: 10.1097/cej.0000000000000480] [Cited by in Crossref: 61] [Cited by in F6Publishing: 66] [Article Influence: 20.3] [Reference Citation Analysis]
69 Corso G, Montagna G, Figueiredo J, La Vecchia C, Fumagalli Romario U, Fernandes MS, Seixas S, Roviello F, Trovato C, Guerini-Rocco E, Fusco N, Pravettoni G, Petrocchi S, Rotili A, Massari G, Magnoni F, De Lorenzi F, Bottoni M, Galimberti V, Sanches JM, Calvello M, Seruca R, Bonanni B. Hereditary Gastric and Breast Cancer Syndromes Related to CDH1 Germline Mutation: A Multidisciplinary Clinical Review. Cancers (Basel) 2020;12:E1598. [PMID: 32560361 DOI: 10.3390/cancers12061598] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
70 Bharucha PP, Chiu KE, François FM, Scott JL, Khorjekar GR, Tirada NP. Genetic Testing and Screening Recommendations for Patients with Hereditary Breast Cancer. RadioGraphics 2020;40:913-36. [DOI: 10.1148/rg.2020190181] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
71 Niemeyer E, Mofid H, Zornig C, Burandt EC, Stein A, Block A, Volk AE. Case report: acute abdominal pain in a 37-year-old patient and the consequences for his family. BMC Gastroenterol 2020;20:129. [PMID: 32362280 DOI: 10.1186/s12876-020-01283-2] [Reference Citation Analysis]
72 Aronson M, Swallow C, Govindarajan A, Semotiuk K, Cohen Z, Kaurah P, Velsher L, Ambus I, Buckley K, Forster-Gibson C, Meschino WS, Blumenthal A, Kim RH, Brar S. Germline variants and phenotypic spectrum in a Canadian cohort of individuals with diffuse gastric cancer. Curr Oncol 2020;27:e182-90. [PMID: 32489267 DOI: 10.3747/co.27.5663] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
73 Van Cott C. Cancer Genetics. Surg Clin North Am 2020;100:483-98. [PMID: 32402295 DOI: 10.1016/j.suc.2020.02.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
74 Laszkowska M, Silver ER, Schrope B, Kastrinos F, Wang TC, Hur C. Optimal Timing of Total Gastrectomy to Prevent Diffuse Gastric Cancer in Individuals With Pathogenic Variants in CDH1. Clin Gastroenterol Hepatol 2020;18:822-829.e4. [PMID: 31220641 DOI: 10.1016/j.cgh.2019.06.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
75 Yadav S, Hu C, Hart SN, Boddicker N, Polley EC, Na J, Gnanaolivu R, Lee KY, Lindstrom T, Armasu S, Fitz-Gibbon P, Ghosh K, Stan DL, Pruthi S, Neal L, Sandhu N, Rhodes DJ, Klassen C, Peethambaram PP, Haddad TC, Olson JE, Hoskin TL, Goetz MP, Domchek SM, Boughey JC, Ruddy KJ, Couch FJ. Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer. J Clin Oncol 2020;38:1409-18. [PMID: 32125938 DOI: 10.1200/JCO.19.02190] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 9.3] [Reference Citation Analysis]
76 Douridas GN, Fountoulakis A, Souglakos J, Gourtsoyianni S, Vini L, Levidou G, Liakakos T, Agalianos C, Dervenis C, Kalogeridi MA, Karavokyros I, Koumarianou A, Kountourakis P, Oikonomopoulos G, Economopoulou P, Sgouros J, Sgouros SN, Stamou K, Triantopoulou C, Zacharoulis D, Gouvas N, Xynos E. Consensus statement of the Hellenic and Cypriot Gastric Cancer Study Group on the diagnosis, staging and management of gastric cancer. Updates Surg 2020;72:1-19. [PMID: 32112342 DOI: 10.1007/s13304-020-00723-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
77 Mousa H, Yuan M, Zhang X, Li X, Shopit A, Almoiliqy M, Alshwmi M, Al-Dherasi A, Xu Y, Zuo Y. MicroRNA-4316 inhibits gastric cancer proliferation and migration via directly targeting VEGF-A. Cancer Cell Int 2020;20:62. [PMID: 32123520 DOI: 10.1186/s12935-020-1132-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
78 Shin HC, Lee HB, Yoo TK, Lee ES, Kim RN, Park B, Yoon KA, Park C, Lee ES, Moon HG, Noh DY, Kong SY, Han W. Detection of Germline Mutations in Breast Cancer Patients with Clinical Features of Hereditary Cancer Syndrome Using a Multi-Gene Panel Test. Cancer Res Treat 2020;52:697-713. [PMID: 32019277 DOI: 10.4143/crt.2019.559] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
79 Moridnia A, Tabatabaiefar MA, Zeinalian M, Minakari M, Kheirollahi M, Moghaddam NA. Novel Variants and Copy Number Variation in CDH1 Gene in Iranian Patients with Sporadic Diffuse Gastric Cancer. J Gastrointest Cancer 2019;50:420-7. [PMID: 29577179 DOI: 10.1007/s12029-018-0082-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
80 Zhang Q, Yang Z, Karamchandani DM. Complete histopathologic examination of risk reduction gastrectomy specimens for CDH1 germline mutation: Is it warranted in routine clinical practice? Ann Diagn Pathol 2020;45:151473. [PMID: 31986421 DOI: 10.1016/j.anndiagpath.2020.151473] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
81 Rädle J. Hereditäre Tumorerkrankungen – Diagnostik und Überwachungsstrategien. Prävention gastroenterologischer Tumorerkrankungen 2020. [DOI: 10.1007/978-3-662-58879-6_9] [Reference Citation Analysis]
82 Walsh MF, Cadoo K, Salo-mullen EE, Dubard-gault M, Stadler ZK, Offit K. Genetic Factors. Abeloff's Clinical Oncology 2020. [DOI: 10.1016/b978-0-323-47674-4.00013-x] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
83 Shenoy S. CDH1 (E-Cadherin) Mutation and Gastric Cancer: Genetics, Molecular Mechanisms and Guidelines for Management. Cancer Manag Res 2019;11:10477-86. [PMID: 31853199 DOI: 10.2147/CMAR.S208818] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 10.8] [Reference Citation Analysis]
84 Lim JH. How to Apply Genetic Analysis for Hereditary Diffuse Gastric Cancer? Korean J Helicobacter Up Gastrointest Res 2019;19:289-290. [DOI: 10.7704/kjhugr.2019.0029] [Reference Citation Analysis]
85 Webster R, Bannon SA, Hyde SM, Woodson AH, You NY, Lu KH, Arun B. Hereditary Cancer Syndromes: Risk Assessment and Genetic Counseling. Holland‐Frei Cancer Medicine 2019. [DOI: 10.1002/9781119000822.hfcm143] [Reference Citation Analysis]
86 Liao S, Liu C, Zhu G, Wang K, Yang Y, Wang C. Relationship between SDC1 and cadherin signalling activation in cancer. Pathol Res Pract 2020;216:152756. [PMID: 31810587 DOI: 10.1016/j.prp.2019.152756] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
87 Du S, Yang Y, Yi P, Luo J, Liu T, Chen R, Liu CJ, Ma T, Li Y, Wang C, Weng J, Liu M, Zhang L, Yang B, Zeng X, Liu JY. A Novel CDH1 Mutation Causing Reduced E-Cadherin Dimerization Is Associated with Nonsyndromic Cleft Lip With or Without Cleft Palate. Genet Test Mol Biomarkers 2019;23:759-65. [PMID: 31638429 DOI: 10.1089/gtmb.2019.0092] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
88 Vogelsang HE. Prophylactic Surgery and Extended Oncologic Radicality in Gastric and Colorectal Hereditary Cancer Syndromes. Visc Med 2019;35:231-9. [PMID: 31602384 DOI: 10.1159/000501919] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
89 Norero E, Alarcon MA, Hakkaart C, de Mayo T, Mellado C, Garrido M, Aguayo G, Lagos M, Torres J, Calvo A, Guilford P, Corvalan AH. Identification of c.1531C>T Pathogenic Variant in the CDH1 Gene as a Novel Germline Mutation of Hereditary Diffuse Gastric Cancer. Int J Mol Sci 2019;20:E4980. [PMID: 31600923 DOI: 10.3390/ijms20204980] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
90 Catherine Framp A, McAllister M, Dwyer T. Narrative research methods with vulnerable people: sharing insights. Nurse Res 2019;27:42-7. [PMID: 31802652 DOI: 10.7748/nr.2019.e1671] [Reference Citation Analysis]
91 Tedaldi G, Pirini F, Tebaldi M, Zampiga V, Cangini I, Danesi R, Arcangeli V, Ravegnani M, Abou Khouzam R, Molinari C, Oliveira C, Morgagni P, Saragoni L, Bencivenga M, Ulivi P, Amadori D, Martinelli G, Falcini F, Ranzani GN, Calistri D. Multigene Panel Testing Increases the Number of Loci Associated with Gastric Cancer Predisposition. Cancers (Basel) 2019;11:E1340. [PMID: 31514334 DOI: 10.3390/cancers11091340] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
92 Piccinin C, Panchal S, Watkins N, Kim RH. An update on genetic risk assessment and prevention: the role of genetic testing panels in breast cancer. Expert Rev Anticancer Ther 2019;19:787-801. [PMID: 31469018 DOI: 10.1080/14737140.2019.1659730] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
93 Banks M, Graham D, Jansen M, Gotoda T, Coda S, di Pietro M, Uedo N, Bhandari P, Pritchard DM, Kuipers EJ, Rodriguez-Justo M, Novelli MR, Ragunath K, Shepherd N, Dinis-Ribeiro M. British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut 2019;68:1545-75. [PMID: 31278206 DOI: 10.1136/gutjnl-2018-318126] [Cited by in Crossref: 203] [Cited by in F6Publishing: 184] [Article Influence: 50.8] [Reference Citation Analysis]
94 Roberts ME, Ranola JMO, Marshall ML, Susswein LR, Graceffo S, Bohnert K, Tsai G, Klein RT, Hruska KS, Shirts BH. Comparison of CDH1 Penetrance Estimates in Clinically Ascertained Families vs Families Ascertained for Multiple Gastric Cancers. JAMA Oncol 2019;5:1325-31. [PMID: 31246251 DOI: 10.1001/jamaoncol.2019.1208] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 15.3] [Reference Citation Analysis]
95 Beetham H, Chen A, Telford BJ, Single A, Jarman KE, Lackovic K, Luxenburger A, Guilford P. A high-throughput screen to identify novel synthetic lethal compounds for the treatment of E-cadherin-deficient cells. Sci Rep 2019;9:12511. [PMID: 31467357 DOI: 10.1038/s41598-019-48929-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
96 Xicola RM, Li S, Rodriguez N, Reinecke P, Karam R, Speare V, Black MH, Laduca H, Llor X. Clinical features and cancer risk in families with pathogenic CDH1 variants irrespective of clinical criteria. J Med Genet 2019;56:838-43. [DOI: 10.1136/jmedgenet-2019-105991] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 10.3] [Reference Citation Analysis]
97 Jacobs MF, Dust H, Koeppe E, Wong S, Mulholland M, Choi EY, Appelman H, Stoffel EM. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer. Gastroenterology 2019;157:87-96. [PMID: 30935944 DOI: 10.1053/j.gastro.2019.03.047] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
98 Kumar S, Long JM, Ginsberg GG, Katona BW. The role of endoscopy in the management of hereditary diffuse gastric cancer syndrome. World J Gastroenterol 2019; 25(23): 2878-2886 [PMID: 31249446 DOI: 10.3748/wjg.v25.i23.2878] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
99 Demeure MJ. The Role of Precision Medicine in the Diagnosis and Treatment of Patients with Rare Cancers. Cancer Treat Res 2019;178:81-108. [PMID: 31209842 DOI: 10.1007/978-3-030-16391-4_3] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
100 Ruff S, Curtin B, Quezado M, Heller T, Koh C, Steinberg SM, Connolly M, Hernandez JM, Davis JL. Evaluation of confocal endoscopic microscopy for detection of early-stage gastric cancer in hereditary diffuse gastric cancer (HDGC) syndrome. J Gastrointest Oncol. 2019;10:407-411. [PMID: 31183189 DOI: 10.21037/jgo.2019.01.04] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
101 Lott PC, Carvajal-Carmona LG. Resolving gastric cancer aetiology: an update in genetic predisposition. Lancet Gastroenterol Hepatol. 2018;3:874-883. [PMID: 30507471 DOI: 10.1016/s2468-1253(18)30237-1] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 12.0] [Reference Citation Analysis]
102 Paul P, Malakar AK, Chakraborty S. The significance of gene mutations across eight major cancer types. Mutat Res Rev Mutat Res 2019;781:88-99. [PMID: 31416581 DOI: 10.1016/j.mrrev.2019.04.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
103 Tiwari R, Singh AK, Somwaru AS, Menias CO, Prasad SR, Katabathina VS. Radiologist’s Primer on Imaging of Common Hereditary Cancer Syndromes. RadioGraphics 2019;39:759-78. [DOI: 10.1148/rg.2019180171] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
104 Cohen-haguenauer O. Prédisposition héréditaire au cancer du sein (2): Risques et prise en charge. Med Sci (Paris) 2019;35:332-45. [DOI: 10.1051/medsci/2019072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
105 Lima ZS, Ghadamzadeh M, Arashloo FT, Amjad G, Ebadi MR, Younesi L. Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigms. J Hematol Oncol 2019;12:38. [PMID: 30975222 DOI: 10.1186/s13045-019-0725-6] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 10.8] [Reference Citation Analysis]
106 Lynch HT, Nustas R, Kassim T, Snyder C, Shaw T, Diab O. The benefits of a model of interval comprehensive assessments (MICA) in hereditary cancer Syndromes: Hereditary diffuse gastric cancer (HDGC) as an example. Cancer Genetics 2019;233-234:43-7. [DOI: 10.1016/j.cancergen.2019.03.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
107 De Scalzi AM, Bonanni B, Galimberti V, Veronesi P, Pravettoni G, Corso G. E-cadherin germline mutations in Māori population. Future Oncology 2019;15:1291-4. [DOI: 10.2217/fon-2018-0834] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
108 Hamilton JG, Long JM, Brandt AC, Brower J, Symecko H, Salo-Mullen EE, Christian SN, Harstad T, Couch FJ, Garber JE, Offit K, Robson ME, Domchek SM. Patients' Medical and Psychosocial Experiences After Detection of a CDH1 Variant With Multigene Panel Testing. JCO Precis Oncol 2019;3. [PMID: 31511843 DOI: 10.1200/PO.18.00300] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
109 Guindalini RSC, Cormedi MCV, Maistro S, Pasini FS, Branas PCAA, Dos Santos L, de Lima Pereira GF, de Bock GH, Saccaro DM, Katayama MLH, Faraj SF, Safatle-Ribeiro A, Ribeiro Junior U, Diz MDPE, de Gouvêa ACRC, Chammas R, Folgueira MAAK. Frequency of CDH1 germline variants and contribution of dietary habits in early age onset gastric cancer patients in Brazil. Gastric Cancer 2019;22:920-31. [PMID: 30895400 DOI: 10.1007/s10120-019-00945-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
110 Donida BM, Tomasello G, Ghidini M, Buffoli F, Grassi M, Liguigli W, Maglietta G, Pergola L, Ratti M, Sabadini G, Toppo L, Ungari M, Passalacqua R. Epidemiological, clinical and pathological characteristics of gastric neoplasms in the province of Cremona: the experience of the first population-based specialized gastric cancer registry in Italy. BMC Cancer 2019;19:212. [PMID: 30849945 DOI: 10.1186/s12885-019-5366-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
111 Guo L, Liu Z, Zhang Y, Quan Q, Huang L, Xu Y, Cao L, Zhang X. Association of increased B7 protein expression by infiltrating immune cells with progression of gastric carcinogenesis. Medicine (Baltimore) 2019;98:e14663. [PMID: 30813210 DOI: 10.1097/MD.0000000000014663] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
112 Muto Y, Suzuki K, Kato T, Ichida K, Takayama Y, Fukui T, Kakizawa N, Watanabe F, Kaneda Y, Noda H, Rikiyama T. Multiple primary malignancies of six organs in a Japanese male patient: A case report. Mol Clin Oncol 2019;10:511-5. [PMID: 30967945 DOI: 10.3892/mco.2019.1819] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
113 Cohen-Haguenauer O. [Hereditary predisposition to breast cancer (1): genetics]. Med Sci (Paris) 2019;35:138-51. [PMID: 30774081 DOI: 10.1051/medsci/2019003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
114 Figueiredo J, Melo S, Carneiro P, Moreira AM, Fernandes MS, Ribeiro AS, Guilford P, Paredes J, Seruca R. Clinical spectrum and pleiotropic nature of CDH1 germline mutations. J Med Genet. 2019;56:199-208. [PMID: 30661051 DOI: 10.1136/jmedgenet-2018-105807] [Cited by in Crossref: 48] [Cited by in F6Publishing: 53] [Article Influence: 12.0] [Reference Citation Analysis]
115 Schubert S, van Luttikhuizen JL, Auber B, Schmidt G, Hofmann W, Penkert J, Davenport CF, Hille-Betz U, Wendeburg L, Bublitz J, Tauscher M, Hackmann K, Schröck E, Scholz C, Wallaschek H, Schlegelberger B, Illig T, Steinemann D. The identification of pathogenic variants in BRCA1/2 negative, high risk, hereditary breast and/or ovarian cancer patients: High frequency of FANCM pathogenic variants. Int J Cancer 2019;144:2683-94. [PMID: 30426508 DOI: 10.1002/ijc.31992] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 8.3] [Reference Citation Analysis]
116 Setoyama T, Miyamoto S, Nikaido M, Seno H. New Perspectives in Gastric Cancer: Helicobacter pylori-Uninfected Pure Signet Ring Cell Carcinoma. Alcoholic/Non-Alcoholic Digestive Diseases 2019. [DOI: 10.1007/978-981-13-1465-0_4] [Reference Citation Analysis]
117 Rao R, Mauer CB, Chen-seetoo M, Peng Y. Breast Cancer with Hereditary Cancer Predisposition Syndromes. Practical Breast Pathology 2019. [DOI: 10.1007/978-3-030-16518-5_8] [Reference Citation Analysis]
118 De Re V, Dolcetti R. Genetic and Epigenetic Mechanisms in Gastric Cancer. Current Clinical Pathology 2019. [DOI: 10.1007/978-3-030-04861-7_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
119 Thirumurthi S, Vilar E, Lynch PJ. Hereditary Gastrointestinal Cancers. Textbook of Gastrointestinal Oncology 2019. [DOI: 10.1007/978-3-030-18890-0_33] [Reference Citation Analysis]
120 van der Kaaij RT, van Kessel JP, van Dieren JM, Snaebjornsson P, Balagué O, van Coevorden F, van der Kolk LE, Sikorska K, Cats A, van Sandick JW. Outcomes after prophylactic gastrectomy for hereditary diffuse gastric cancer. Br J Surg 2018;105:e176-82. [PMID: 29341148 DOI: 10.1002/bjs.10754] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
121 Luo W, Fedda F, Lynch P, Tan D. CDH1 Gene and Hereditary Diffuse Gastric Cancer Syndrome: Molecular and Histological Alterations and Implications for Diagnosis And Treatment. Front Pharmacol. 2018;9:1421. [PMID: 30568591 DOI: 10.3389/fphar.2018.01421] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 8.4] [Reference Citation Analysis]
122 Benusiglio PR, Colas C, Guillerm E, Canard A, Delhomelle H, Warcoin M, Bellanger J, Eyries M, Zizi M, Netter J, Soubrier F, Parc Y, Mourregot A, Maran Gonzalez A, Cusin V, Denis JA, Coupier I, Svrcek M, Coulet F. Clinical implications of CTNNA1 germline mutations in asymptomatic carriers. Gastric Cancer 2019;22:899-903. [PMID: 30515673 DOI: 10.1007/s10120-018-00907-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
123 Vangala DB, Cauchin E, Balmaña J, Wyrwicz L, van Cutsem E, Güller U, Castells A, Carneiro F, Hammel P, Ducreux M, van Laethem JL, Matysiak-Budnik T, Schmiegel W. Screening and surveillance in hereditary gastrointestinal cancers: Recommendations from the European Society of Digestive Oncology (ESDO) expert discussion at the 20th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona, June 2018. Eur J Cancer 2018;104:91-103. [PMID: 30342310 DOI: 10.1016/j.ejca.2018.09.004] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 7.6] [Reference Citation Analysis]
124 Polom K, Marrelli D, Voglino C, Roviello G, De Franco L, Vindigni C, Generali D, Roviello F. Familial aggregation of gastric cancer with microsatellite instability. Acta Chir Belg 2018;118:287-93. [PMID: 30071769 DOI: 10.1080/00015458.2017.1379789] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
125 Medrado BF, da Costa Martins B. The Role of Endoscopy. In: de Castria TB, Guindalini RSC, editors. Diffuse Gastric Cancer. Cham: Springer International Publishing; 2018. pp. 15-25. [DOI: 10.1007/978-3-319-95234-5_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
126 Lyubchenko LN, Filippova MG, Anurova OA, Nazliev PB, Stilidi IS. HEREDITARY DIFFUSE GASTRIC CANCER: GENETIC ASPECTS AND PROPHYLACTIC TOTAL GASTRECTOMY. Sib onkol ž 2018;17:48-52. [DOI: 10.21294/1814-4861-2018-17-4-48-52] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
127 Moslim MA, Heald B, Tu C, Burke CA, Walsh RM. Early genetic counseling and detection of CDH1 mutation in asymptomatic carriers improves survival in hereditary diffuse gastric cancer. Surgery. 2018;164:754-759. [PMID: 30145018 DOI: 10.1016/j.surg.2018.05.059] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
128 Ansari S, Gantuya B, Tuan VP, Yamaoka Y. Diffuse Gastric Cancer: A Summary of Analogous Contributing Factors for Its Molecular Pathogenicity. Int J Mol Sci 2018;19:E2424. [PMID: 30115886 DOI: 10.3390/ijms19082424] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 8.0] [Reference Citation Analysis]
129 de Castro Sant' Anna C, Junior AGF, Soares P, Tuji F, Paschoal E, Chaves LC, Burbano RR. Molecular biology as a tool for the treatment of cancer. Clin Exp Med 2018;18:457-64. [PMID: 30006681 DOI: 10.1007/s10238-018-0518-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
130 Polom K, Marrelli D, D'Ignazio A, Roviello F. Hereditary diffuse gastric cancer: how to look for and how to manage it. Updates Surg. 2018;70:161-166. [PMID: 29869323 DOI: 10.1007/s13304-018-0545-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
131 Sahni M, Goel A, Pande P, Kumar K. Multiple Gastrointestinal Cancers in a Single Patient-a Rare Clinical Entity. Indian J Surg Oncol 2018;9:633-5. [PMID: 30538406 DOI: 10.1007/s13193-018-0770-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
132 Spoto CP, Gullo I, Carneiro F, Montgomery EA, Brosens LA. Hereditary gastrointestinal carcinomas and their precursors: An algorithm for genetic testing. Seminars in Diagnostic Pathology 2018;35:170-83. [DOI: 10.1053/j.semdp.2018.01.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
133 Molaei F, Forghanifard MM, Fahim Y, Abbaszadegan MR. Molecular Signaling in Tumorigenesis of Gastric Cancer. Iran Biomed J. 2018;22:217-230. [PMID: 29706061 DOI: 10.22034/ibj.22.4.217] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
134 Fewings E, Larionov A, Redman J, Goldgraben MA, Scarth J, Richardson S, Brewer C, Davidson R, Ellis I, Evans DG, Halliday D, Izatt L, Marks P, McConnell V, Verbist L, Mayes R, Clark GR, Hadfield J, Chin SF, Teixeira MR, Giger OT, Hardwick R, di Pietro M, O'Donovan M, Pharoah P, Caldas C, Fitzgerald RC, Tischkowitz M. Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study. Lancet Gastroenterol Hepatol 2018;3:489-98. [PMID: 29706558 DOI: 10.1016/S2468-1253(18)30079-7] [Cited by in Crossref: 54] [Cited by in F6Publishing: 60] [Article Influence: 10.8] [Reference Citation Analysis]
135 Zakko L, Lutzke L, Wang KK. Screening and Preventive Strategies in Esophagogastric Cancer. Surg Oncol Clin N Am 2017;26:163-78. [PMID: 28279462 DOI: 10.1016/j.soc.2016.10.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
136 Chan MQ, Blum AE, Chandar AK, Emmons AMLK, Shindo Y, Brock W, Falk GW, Canto MI, Wang JS, Iyer PG, Shaheen NJ, Grady WM, Abrams JA, Thota PN, Guda KK, Chak A. Association of sporadic and familial Barrett's esophagus with breast cancer. Dis Esophagus 2018;31. [PMID: 29528378 DOI: 10.1093/dote/doy007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
137 Song M, Camargo MC, Weinstein SJ, Best AF, Männistö S, Albanes D, Rabkin CS. Family history of cancer in first-degree relatives and risk of gastric cancer and its precursors in a Western population. Gastric Cancer 2018;21:729-37. [PMID: 29455268 DOI: 10.1007/s10120-018-0807-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
138 Kim RH, Chu QD, Li BD. Gastric Adenocarcinoma. The American Cancer Society's Oncology in Practice 2018. [DOI: 10.1002/9781118592168.ch4] [Reference Citation Analysis]
139 de Almeida Artifon EL, Marinho FRT. Endoscopic screening for hereditary diffuse gastric cancer: one size does not fit all. Gastrointest Endosc 2018;87:405-7. [PMID: 29406927 DOI: 10.1016/j.gie.2017.05.042] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
140 van der Post RS, van Dieren J, Grelack A, Hoogerbrugge N, van der Kolk LE, Snaebjornsson P, Lansdorp-Vogelaar I, van Krieken JH, Bisseling TM, Cats A. Outcomes of screening gastroscopy in first-degree relatives of patients fulfilling hereditary diffuse gastric cancer criteria. Gastrointest Endosc 2018;87:397-404.e2. [PMID: 28455161 DOI: 10.1016/j.gie.2017.04.016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
141 Zylberberg HM, Sultan K, Rubin S. Hereditary diffuse gastric cancer: One family’s story. World J Clin Cases 2018; 6(1): 1-5 [PMID: 29376063 DOI: 10.12998/wjcc.v6.i1.1] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
142 Weren RDA, van der Post RS, Vogelaar IP, van Krieken JH, Spruijt L, Lubinski J, Jakubowska A, Teodorczyk U, Aalfs CM, van Hest LP, Oliveira C, Kamping EJ, Schackert HK, Ranzani GN, Gómez García EB, Hes FJ, Holinski-Feder E, Genuardi M, Ausems MGEM, Sijmons RH, Wagner A, van der Kolk LE, Cats A, Bjørnevoll I, Hoogerbrugge N, Ligtenberg MJL. Role of germline aberrations affecting CTNNA1, MAP3K6 and MYD88 in gastric cancer susceptibility. J Med Genet 2018;55:669-74. [PMID: 29330337 DOI: 10.1136/jmedgenet-2017-104962] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 5.6] [Reference Citation Analysis]
143 Price KS, Svenson A, King E, Ready K, Lazarin GA. Inherited Cancer in the Age of Next-Generation Sequencing. Biol Res Nurs 2018;20:192-204. [PMID: 29325452 DOI: 10.1177/1099800417750746] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
144 Lee HE, Smyrk TC, Zhang L. Histologic and immunohistochemical differences between hereditary and sporadic diffuse gastric carcinoma. Hum Pathol 2018;74:64-72. [PMID: 29307626 DOI: 10.1016/j.humpath.2017.12.023] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
145 Ribeiro U, Perrotta FS. The Role of Surgery. Diffuse Gastric Cancer 2018. [DOI: 10.1007/978-3-319-95234-5_6] [Reference Citation Analysis]
146 Sepulveda AR, J. Del Portillo A. Molecular Basis of Diseases of the Gastrointestinal Tract. Molecular Pathology 2018. [DOI: 10.1016/b978-0-12-802761-5.00019-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
147 Zhang H, Feng M, Feng Y, Bu Z, Li Z, Jia S, Ji J. Germline mutations in hereditary diffuse gastric cancer. Chin J Cancer Res 2018;30:122-30. [PMID: 29545726 DOI: 10.21147/j.issn.1000-9604.2018.01.13] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
148 de Gouvea ACRC, Silva ACB, Victor CR, Mendoza EZ, Nardo M, Guindalini RSC. Genetic Predisposition and Hereditary Syndromes. Diffuse Gastric Cancer 2018. [DOI: 10.1007/978-3-319-95234-5_5] [Reference Citation Analysis]
149 O'donnell M, Axilbund J, Euhus DM. Breast Cancer Genetics. The Breast 2018. [DOI: 10.1016/b978-0-323-35955-9.00017-9] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
150 Wen HY, Brogi E. Lobular Carcinoma In Situ. Surg Pathol Clin 2018;11:123-45. [PMID: 29413653 DOI: 10.1016/j.path.2017.09.009] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
151 Bleaney CW, Barrow M, Hayes S, Ang Y. The relevance and implications of signet-ring cell adenocarcinoma of the oesophagus. J Clin Pathol 2018;71:201-6. [PMID: 29212656 DOI: 10.1136/jclinpath-2017-204863] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
152 Mommersteeg MC, Yu J, Peppelenbosch MP, Fuhler GM. Genetic host factors in Helicobacter pylori-induced carcinogenesis: Emerging new paradigms. Biochim Biophys Acta Rev Cancer. 2018;1869:42-52. [PMID: 29154808 DOI: 10.1016/j.bbcan.2017.11.003] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 6.8] [Reference Citation Analysis]
153 Strong VE, Gholami S, Shah MA, Tang LH, Janjigian YY, Schattner M, Selby LV, Yoon SS, Salo-Mullen E, Stadler ZK, Kelsen D, Brennan MF, Coit DG. Total Gastrectomy for Hereditary Diffuse Gastric Cancer at a Single Center: Postsurgical Outcomes in 41 Patients. Ann Surg 2017;266:1006-12. [PMID: 27759617 DOI: 10.1097/SLA.0000000000002030] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 6.2] [Reference Citation Analysis]
154 Caggiari L, Miolo G, Canzonieri V, De Zorzi M, Alessandrini L, Corona G, Cannizzaro R, Santeufemia DA, Cossu A, Buonadonna A, De Re V. A new mutation of the CDH1 gene in a patient with an aggressive signet-ring cell carcinoma of the stomach. Cancer Biol Ther 2018;19:254-9. [PMID: 29131691 DOI: 10.1080/15384047.2017.1394540] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
155 Fan H, Lu P, Xu L, Qin Y, Li J. Synchronous occurrence of hereditary gastric adenocarcinoma, gastrointestinal stromal tumor, and esophageal small cell and squamous carcinoma in situ: an extremely rare case report. BMC Cancer. 2017;17:720. [PMID: 29115925 DOI: 10.1186/s12885-017-3736-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
156 Moradi M, Yari K, Rahimi Z. The GPX1 Pro198Leu polymorphism in gastric cancer patients with and without Helicobacter pylori infection. Genes Genom 2017;39:1265-1269. [DOI: 10.1007/s13258-017-0594-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
157 Malik F, Ali N, Durrani J, Mustafa SI, Denlinger C. Case series of multiple primary cancers in single individuals: diagnostic and therapeutic dilemmas. J Community Hosp Intern Med Perspect 2017;7:238-40. [PMID: 29046751 DOI: 10.1080/20009666.2017.1369377] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
158 Stuebs F, Heidemann S, Caliebe A, Mundhenke C, Arnold N. CDH1 mutation screen in a BRCA1/2-negative familial breast-/ovarian cancer cohort. Arch Gynecol Obstet 2018;297:147-52. [PMID: 28993866 DOI: 10.1007/s00404-017-4551-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
159 Hallowell N, Badger S, Richardson S, Caldas C, Hardwick RH, Fitzgerald RC, Lawton J. An investigation of the factors effecting high-risk individuals' decision-making about prophylactic total gastrectomy and surveillance for hereditary diffuse gastric cancer (HDGC). Fam Cancer. 2016;15:665-676. [PMID: 27256430 DOI: 10.1007/s10689-016-9910-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
160 Stoll J, Weissman SM, Hook N, Selkirk C, Johnson AK, Newlin A, Vogel Postula KJ. Evaluation of laboratory perspectives on hereditary cancer panels. Fam Cancer 2016;15:689-96. [PMID: 26869169 DOI: 10.1007/s10689-016-9880-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
161 Tabatabaiefar MA, Moridnia A. Gastrointestinal Cancers. In: Mehdipour P, editor. Cancer Genetics and Psychotherapy. Cham: Springer International Publishing; 2017. pp. 589-625. [DOI: 10.1007/978-3-319-64550-6_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
162 Nie RC, Yuan SQ, Li YF, Chen YM, Chen XJ, Zhu BY, Xu LP, Zhou ZW, Chen S, Chen YB. Clinicopathological Characteristics and Prognostic Value of Signet Ring Cells in Gastric Carcinoma: A Meta-Analysis. J Cancer 2017;8:3396-404. [PMID: 29151922 DOI: 10.7150/jca.21017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
163 Ghersin I, Katz LH. Gastric cancer in a teenager: a case report. Int J Adolesc Med Health 2017;31:/j/ijamh. [PMID: 28779571 DOI: 10.1515/ijamh-2017-0078] [Reference Citation Analysis]
164 Svistunov AA, Osadchuk MA. Stomach diseases unrelated to Helicobacter pylori infection: current state of the problem. Klin med 2017;95:594-598. [DOI: 10.18821/0023-2149-2017-95-7-594-598] [Reference Citation Analysis]
165 Quadri HS, Smaglo BG, Morales SJ, Phillips AC, Martin AD, Chalhoub WM, Haddad NG, Unger KR, Levy AD, Al-Refaie WB. Gastric Adenocarcinoma: A Multimodal Approach.Front Surg. 2017;4:42. [PMID: 28824918 DOI: 10.3389/fsurg.2017.00042] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
166 Kim Y, Cho MY, Kim J, Kim SN, Oh SC, Lee KA. Profiling cancer-associated genetic alterations and molecular classification of cancer in Korean gastric cancer patients. Oncotarget 2017;8:69888-905. [PMID: 29050249 DOI: 10.18632/oncotarget.19435] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
167 Betés M, Alonso-Sierra M, Valentí V, Patiño A. A multidisciplinary approach allows identification of a new pathogenic CDH1 germline missense mutation in a hereditary diffuse gastric cancer family. Dig Liver Dis 2017;49:825-6. [PMID: 28487081 DOI: 10.1016/j.dld.2017.04.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
168 Langner C. Hereditäres Magen- und Pankreaskarzinom. Pathologe 2017;38:164-9. [DOI: 10.1007/s00292-017-0297-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
169 Chin JY, Hong TS. Gastric Cancer. Clinical Radiation Oncology 2017. [DOI: 10.1002/9781119341154.ch21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
170 Strand MS, Lockhart AC, Fields RC. Genetics of Gastric Cancer. Surg Clin North Am. 2017;97:345-370. [PMID: 28325191 DOI: 10.1016/j.suc.2016.11.009] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
171 Marks D, Mchenry A, Biagi T, Stark E, Borum M, Lin P, Kaltman R. A Life Potentially Saved Through Hereditary Cancer Panel Testing. JOP 2017;13:279-281. [DOI: 10.1200/jop.2016.016170] [Reference Citation Analysis]
172 Shah MA. Future Directions in Improving Outcomes for Patients with Gastric and Esophageal Cancer. Hematol Oncol Clin North Am 2017;31:545-52. [PMID: 28501093 DOI: 10.1016/j.hoc.2017.01.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
173 Popa E, Schnoll-sussman F, Jesudian A, Nandakumar G, Shah MA. Uncommon Cancers of the Stomach. Textbook of Uncommon Cancer 2017. [DOI: 10.1002/9781119196235.ch27] [Reference Citation Analysis]
174 Boland CR, Yurgelun MB. Historical Perspective on Familial Gastric Cancer. Cell Mol Gastroenterol Hepatol 2017;3:192-200. [PMID: 28275686 DOI: 10.1016/j.jcmgh.2016.12.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
175 Li L, Fan X. Molecular Pathology of Heredity Gastric Cancer. Personalized Management of Gastric Cancer 2017. [DOI: 10.1007/978-981-10-3978-2_1] [Reference Citation Analysis]
176 Schumacher J. Familiäre Magenkarzinome. Moderne Chirurgie des Magen- und Kardiakarzinoms 2017. [DOI: 10.1007/978-3-662-53188-4_3] [Reference Citation Analysis]
177 Matsuyama J, Yamamoto M, Taguchi K, Uezu I, Kawano H, Yoshida D, Minami K, Ikebe M, Morita M, Toh Y. A Young Case of Clinical Hereditary Gastric Cancer with 183 Lesions. Jpn J Gastroenterol Surg, Nihon Shokaki Geka Gakkai zasshi 2017;50:357-363. [DOI: 10.5833/jjgs.2016.0063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
178 Laduca H, Li S, Stuenkel AJ, Speare V, Dolinsky JS, Chao EC. Diagnosing Hereditary Cancer Susceptibility Through Multigene Panel Testing. Next Generation Sequencing Based Clinical Molecular Diagnosis of Human Genetic Disorders 2017. [DOI: 10.1007/978-3-319-56418-0_8] [Reference Citation Analysis]
179 Vogelaar IP, Ligtenberg MJ, van der Post RS, de Voer RM, Kets CM, Jansen TJ, Jacobs L, Schreibelt G, de Vries IJ, Netea MG, Hoogerbrugge N; International Gastric Cancer Genetics Group. Recurrent candidiasis and early-onset gastric cancer in a patient with a genetically defined partial MYD88 defect. Fam Cancer 2016;15:289-96. [PMID: 26700889 DOI: 10.1007/s10689-015-9859-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
180 Brandão C, Dinis-Ribeiro M. Early diagnosis of hereditary diffuse gastric cancer: (not only) an endoscopic challenge! Endosc Int Open 2016;4:E1311-2. [PMID: 27995194 DOI: 10.1055/s-0042-121003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
181 Shepard B, Yoder L, Holmes C. Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer. ACG Case Rep J. 2016;3:e179. [PMID: 28008412 DOI: 10.14309/crj.2016.152] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
182 Moreira L, Castells A. Surveillance of patients with hereditary gastrointestinal cancer syndromes. Best Pract Res Clin Gastroenterol 2016;30:923-35. [PMID: 27938787 DOI: 10.1016/j.bpg.2016.10.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
183 Muir J, Aronson M, Esplen MJ, Pollett A, Swallow CJ. Prophylactic Total Gastrectomy: a Prospective Cohort Study of Long-Term Impact on Quality of Life. J Gastrointest Surg 2016;20:1950-8. [PMID: 27752808 DOI: 10.1007/s11605-016-3287-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
184 Yelskaya Z, Bacares R, Salo-Mullen E, Somar J, Lehrich DA, Fasaye GA, Coit DG, Tang LH, Stadler ZK, Zhang L. CDH1 Missense Variant c.1679C>G (p.T560R) Completely Disrupts Normal Splicing through Creation of a Novel 5' Splice Site. PLoS One. 2016;11:e0165654. [PMID: 27880784 DOI: 10.1371/journal.pone.0165654] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
185 Hallowell N, Lawton J, Badger S, Richardson S, Hardwick RH, Caldas C, Fitzgerald RC. The Psychosocial Impact of Undergoing Prophylactic Total Gastrectomy (PTG) to Manage the Risk of Hereditary Diffuse Gastric Cancer (HDGC). J Genet Couns. 2017;26:752-762. [PMID: 27837291 DOI: 10.1007/s10897-016-0045-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
186 van Marcke C, De Leener A, Berlière M, Vikkula M, Duhoux FP. Routine use of gene panel testing in hereditary breast cancer should be performed with caution. Crit Rev Oncol Hematol 2016;108:33-9. [PMID: 27931838 DOI: 10.1016/j.critrevonc.2016.10.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
187 Tejada-Bergés T. Breast Cancer: Genetics and Risk Assessment. Clin Obstet Gynecol 2016;59:673-87. [PMID: 27749364 DOI: 10.1097/GRF.0000000000000236] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
188 Graffeo R, Livraghi L, Pagani O, Goldhirsch A, Partridge AH, Garber JE. Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care. Breast Cancer Res Treat 2016;160:393-410. [DOI: 10.1007/s10549-016-4003-9] [Cited by in Crossref: 42] [Cited by in F6Publishing: 48] [Article Influence: 6.0] [Reference Citation Analysis]
189 Cobain EF, Milliron KJ, Merajver SD. Updates on breast cancer genetics: Clinical implications of detecting syndromes of inherited increased susceptibility to breast cancer. Seminars in Oncology 2016;43:528-35. [DOI: 10.1053/j.seminoncol.2016.10.001] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 5.6] [Reference Citation Analysis]
190 Repak R, Kohoutova D, Podhola M, Rejchrt S, Minarik M, Benesova L, Lesko M, Bures J. The first European family with gastric adenocarcinoma and proximal polyposis of the stomach: case report and review of the literature. Gastrointest Endosc 2016;84:718-25. [PMID: 27343414 DOI: 10.1016/j.gie.2016.06.023] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
191 Petrovchich I, Ford JM. Genetic predisposition to gastric cancer. Semin Oncol. 2016;43:554-559. [PMID: 27899187 DOI: 10.1053/j.seminoncol.2016.08.006] [Cited by in Crossref: 48] [Cited by in F6Publishing: 53] [Article Influence: 6.9] [Reference Citation Analysis]
192 Stoffel EM. Heritable Gastrointestinal Cancer Syndromes. Gastroenterol Clin North Am 2016;45:509-27. [PMID: 27546846 DOI: 10.1016/j.gtc.2016.04.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
193 Hüneburg R, Marwitz T, van Heteren P, Weismüller TJ, Trebicka J, Adam R, Aretz S, Perez Bouza A, Pantelis D, Kalff JC, Nattermann J, Strassburg CP. Chromoendoscopy in combination with random biopsies does not improve detection of gastric cancer foci in CDH1 mutation positive patients. Endosc Int Open 2016;4:E1305-10. [PMID: 27995193 DOI: 10.1055/s-0042-112582] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
194 Hugen S, Thomas RE, German AJ, Burgener IA, Mandigers PJJ. Gastric carcinoma in canines and humans, a review. Vet Comp Oncol 2017;15:692-705. [PMID: 27549077 DOI: 10.1111/vco.12249] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
195 Petráková K. Lobular breast cancer. Onkologie 2016;10:166-169. [DOI: 10.36290/xon.2016.036] [Reference Citation Analysis]
196 Leoz ML, Sánchez A, Carballal S, Ruano L, Ocaña T, Pellisé M, Castells A, Balaguer F, Moreira L. Hereditary gastric and pancreatic cancer predisposition syndromes. Gastroenterología y Hepatología (English Edition) 2016;39:481-93. [DOI: 10.1016/j.gastre.2016.06.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
197 López M, Cervera-Acedo C, Santibáñez P, Salazar R, Sola JJ, Domínguez-Garrido E. A novel mutation in the CDH1 gene in a Spanish family with hereditary diffuse gastric cancer. Springerplus 2016;5:1181. [PMID: 27512640 DOI: 10.1186/s40064-016-2852-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
198 Davidson M, Smyth EC, Cunningham D. Clinical role of ramucirumab alone or in combination with paclitaxel for gastric and gastro-esophageal junction adenocarcinoma. Onco Targets Ther. 2016;9:4539-4548. [PMID: 27524910 DOI: 10.2147/ott.s84153] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
199 Davidson M, Chau I. Immunotherapy for oesophagogastric cancer. Expert Opin Biol Ther 2016;16:1197-207. [PMID: 27409159 DOI: 10.1080/14712598.2016.1213233] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
200 Kim GH, Liang PS, Bang SJ, Hwang JH. Screening and surveillance for gastric cancer in the United States: Is it needed? Gastrointest Endosc 2016;84:18-28. [PMID: 26940296 DOI: 10.1016/j.gie.2016.02.028] [Cited by in Crossref: 117] [Cited by in F6Publishing: 112] [Article Influence: 16.7] [Reference Citation Analysis]
201 Suárez-Arriaga MC, Ribas-Aparicio RM, Ruiz-Tachiquín ME. MicroRNAs in hereditary diffuse gastric cancer. Biomed Rep 2016;5:151-4. [PMID: 27446532 DOI: 10.3892/br.2016.706] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
202 Weitzel JN. The Genetics of Breast Cancer: What the Surgical Oncologist Needs to Know. Surg Oncol Clin N Am 2015;24:705-32. [PMID: 26363538 DOI: 10.1016/j.soc.2015.06.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
203 Chen G, Jiao ZY. Challenge and thought on treatment of diffuse gastric cancer. Shijie Huaren Xiaohua Zazhi 2016; 24(17): 2608-2616 [DOI: 10.11569/wcjd.v24.i17.2608] [Reference Citation Analysis]
204 El-Husny A, Raiol-Moraes M, Amador M, Ribeiro-Dos-Santos AM, Montagnini A, Barbosa S, Silva A, Assumpção P, Ishak G, Santos S, Pinto P, Cruz A, Ribeiro-Dos-Santos Â. CDH1 mutations in gastric cancer patients from northern Brazil identified by Next- Generation Sequencing (NGS). Genet Mol Biol 2016;39:189-98. [PMID: 27192129 DOI: 10.1590/1678-4685-GMB-2014-0342] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
205 Boukir A, Azghari I, El Kabous M, Errihani H. Les syndromes héréditaires prédisposant au cancer gastrique. J Afr Hepato Gastroenterol 2016;10:66-69. [DOI: 10.1007/s12157-015-0641-5] [Reference Citation Analysis]
206 Hung C, Ueng S, Lin Y, Chou W. Metastatic carcinoma of the urinary bladder in a 67-year-old female with underlying triple primary cancers. Journal of Cancer Research and Practice 2016;3:49-53. [DOI: 10.1016/j.jcrpr.2015.09.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
207 de Campos EC, Ribeiro S, Higashi R, Manfredini R, Kfouri D, Cavalcanti TC. Hereditary diffuse gastric cancer: laparoscopic surgical approach associated to rare mutattion of CDH1 gene. Arq Bras Cir Dig 2015;28:149-51. [PMID: 26176257 DOI: 10.1590/S0102-67202015000200017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
208 Sandoval JA, Fernandez-pineda I, Malkan AD. Risk-reduction surgery in pediatric surgical oncology: A perspective. Journal of Pediatric Surgery 2016;51:675-87. [DOI: 10.1016/j.jpedsurg.2016.01.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
209 Donner I, Kiviluoto T, Ristimäki A, Aaltonen LA, Vahteristo P. Exome sequencing reveals three novel candidate predisposition genes for diffuse gastric cancer. Fam Cancer. 2015;14:241-246. [PMID: 25576241 DOI: 10.1007/s10689-015-9778-z] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
210 Lordick F, Janjigian YY. Clinical impact of tumour biology in the management of gastroesophageal cancer. Nat Rev Clin Oncol. 2016;13:348-360. [PMID: 26925958 DOI: 10.1038/nrclinonc.2016.15] [Cited by in Crossref: 93] [Cited by in F6Publishing: 102] [Article Influence: 13.3] [Reference Citation Analysis]
211 Leoz ML, Sánchez A, Carballal S, Ruano L, Ocaña T, Pellisé M, Castells A, Balaguer F, Moreira L. [Hereditary gastric and pancreatic cancer predisposition syndromes]. Gastroenterol Hepatol 2016;39:481-93. [PMID: 26916701 DOI: 10.1016/j.gastrohep.2015.11.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
212 McCall MD, Graham PJ, Bathe OF. Quality of life: A critical outcome for all surgical treatments of gastric cancer. World J Gastroenterol 2016; 22(3): 1101-1113 [PMID: 26811650 DOI: 10.3748/wjg.v22.i3.1101] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
213 van der Post RS, Gullo I, Oliveira C, Tang LH, Grabsch HI, O'Donovan M, Fitzgerald RC, van Krieken H, Carneiro F. Histopathological, Molecular, and Genetic Profile of Hereditary Diffuse Gastric Cancer: Current Knowledge and Challenges for the Future. Adv Exp Med Biol 2016;908:371-91. [PMID: 27573781 DOI: 10.1007/978-3-319-41388-4_18] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 5.1] [Reference Citation Analysis]
214 Vogelaar IP, van der Post RS, van de Vosse E, van Krieken JH, Hoogerbrugge N, Ligtenberg MJ, Gómez García E. Gastric cancer in three relatives of a patient with a biallelic IL12RB1 mutation. Fam Cancer. 2015;14:89-94. [PMID: 25467645 DOI: 10.1007/s10689-014-9764-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
215 Susswein LR, Marshall ML, Nusbaum R, Vogel Postula KJ, Weissman SM, Yackowski L, Vaccari EM, Bissonnette J, Booker JK, Cremona ML, Gibellini F, Murphy PD, Pineda-Alvarez DE, Pollevick GD, Xu Z, Richard G, Bale S, Klein RT, Hruska KS, Chung WK. Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing. Genet Med 2016;18:823-32. [PMID: 26681312 DOI: 10.1038/gim.2015.166] [Cited by in Crossref: 169] [Cited by in F6Publishing: 189] [Article Influence: 21.1] [Reference Citation Analysis]
216 Hata K, Yamamoto Y, Kiyomatsu T, Tanaka T, Kazama S, Nozawa H, Kawai K, Tanaka J, Nishikawa T, Otani K. Hereditary gastrointestinal cancer. Surg Today. 2015; Dec 16. [Epub ahead of print]. [PMID: 26676416 DOI: 10.1007/s00595-015-1283-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
217 Kalady MF, Heald B. Diagnostic Approach to Hereditary Colorectal Cancer Syndromes. Clin Colon Rectal Surg 2015;28:205-14. [PMID: 26664327 DOI: 10.1055/s-0035-1564432] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
218 El-omar EM, Mclean MH. Tumors of the Stomach. Yamada' s Textbook of Gastroenterology 2015. [DOI: 10.1002/9781118512074.ch59] [Reference Citation Analysis]
219 Panos LE, Boland CR. Genetic Counseling for Gastrointestinal Patients. Yamada' s Textbook of Gastroenterology 2015. [DOI: 10.1002/9781118512074.ch47] [Reference Citation Analysis]
220 Zargar A, Miroliaee A, Ahmadi Gooraji S, Hajaghamohammadi A. Determination of Effective Factors on Survival of GI Cancers: Results of Five Years Follow up in Iranian Population. Glob J Health Sci 2015;8:256-66. [PMID: 26755479 DOI: 10.5539/gjhs.v8n6p256] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
221 Pernot S, Voron T, Perkins G, Lagorce-Pages C, Berger A, Taieb J. Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge. World J Gastroenterol 2015; 21(40): 11428-11438 [PMID: 26523107 DOI: 10.3748/wjg.v21.i40.11428] [Cited by in CrossRef: 153] [Cited by in F6Publishing: 168] [Article Influence: 19.1] [Reference Citation Analysis]
222 Suh Y, Yang H. Screening and Early Detection of Gastric Cancer. Surgical Clinics of North America 2015;95:1053-66. [DOI: 10.1016/j.suc.2015.05.012] [Cited by in Crossref: 34] [Cited by in F6Publishing: 41] [Article Influence: 4.3] [Reference Citation Analysis]
223 van der Post RS, Vogelaar IP, Manders P, van der Kolk LE, Cats A, van Hest LP, Sijmons R, Aalfs CM, Ausems MG, Gómez García EB, Wagner A, Hes FJ, Arts N, Mensenkamp AR, van Krieken JH, Hoogerbrugge N, Ligtenberg MJ. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1. Gastroenterology 2015;149:897-906.e19. [PMID: 26072394 DOI: 10.1053/j.gastro.2015.06.003] [Cited by in Crossref: 57] [Cited by in F6Publishing: 62] [Article Influence: 7.1] [Reference Citation Analysis]
224 Setia N, Clark JW, Duda DG, Hong TS, Kwak EL, Mullen JT, Lauwers GY. Familial Gastric Cancers. Oncologist. 2015;20:1365-1377. [PMID: 26424758 DOI: 10.1634/theoncologist.2015-0205] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
225 Slavin TP, Niell-Swiller M, Solomon I, Nehoray B, Rybak C, Blazer KR, Weitzel JN. Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management. Front Oncol 2015;5:208. [PMID: 26484312 DOI: 10.3389/fonc.2015.00208] [Cited by in Crossref: 20] [Cited by in F6Publishing: 63] [Article Influence: 2.5] [Reference Citation Analysis]
226 Tan RYC, Ngeow J. Hereditary diffuse gastric cancer: What the clinician should know. World J Gastrointest Oncol 2015; 7(9): 153-160 [PMID: 26380059 DOI: 10.4251/wjgo.v7.i9.153] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
227 Lin Y, Wu Z, Guo W, Li J. Gene mutations in gastric cancer: a review of recent next-generation sequencing studies. Tumour Biol. 2015;36:7385-7394. [PMID: 26364057 DOI: 10.1007/s13277-015-4002-1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]
228 Chikman B, Davidson T, Kais H, Jeroukhimov I, Leshno A, Sandbank J, Halevy A, Lavy R. Is there an association between invasive lobular carcinoma of the breast and a family history of gastric cancer? Familial Cancer 2016;15:41-7. [DOI: 10.1007/s10689-015-9833-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
229 Yurgelun MB, Allen B, Kaldate RR, Bowles KR, Judkins T, Kaushik P, Roa BB, Wenstrup RJ, Hartman AR, Syngal S. Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome. Gastroenterology 2015;149:604-13.e20. [PMID: 25980754 DOI: 10.1053/j.gastro.2015.05.006] [Cited by in Crossref: 177] [Cited by in F6Publishing: 186] [Article Influence: 22.1] [Reference Citation Analysis]
230 Abdel-Rahman O. Immune checkpoints aberrations and gastric cancer; assessment of prognostic value and evaluation of therapeutic potentials. Crit Rev Oncol Hematol. 2016;97:65-71. [PMID: 26321371 DOI: 10.1016/j.critrevonc.2015.08.015] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
231 Brito LA, Yamamoto GL, Melo S, Malcher C, Ferreira SG, Figueiredo J, Alvizi L, Kobayashi GS, Naslavsky MS, Alonso N, Felix TM, Zatz M, Seruca R, Passos-Bueno MR. Rare Variants in the Epithelial Cadherin Gene Underlying the Genetic Etiology of Nonsyndromic Cleft Lip with or without Cleft Palate. Hum Mutat 2015;36:1029-33. [PMID: 26123647 DOI: 10.1002/humu.22827] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 4.4] [Reference Citation Analysis]
232 Colvin H, Yamamoto K, Wada N, Mori M. Hereditary Gastric Cancer Syndromes. Surg Oncol Clin N Am 2015;24:765-77. [PMID: 26363540 DOI: 10.1016/j.soc.2015.06.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
233 Yamamoto Y, Fujisaki J, Omae M, Hirasawa T, Igarashi M. Helicobacter pylori-negative gastric cancer: characteristics and endoscopic findings. Dig Endosc 2015;27:551-61. [PMID: 25807972 DOI: 10.1111/den.12471] [Cited by in Crossref: 73] [Cited by in F6Publishing: 73] [Article Influence: 9.1] [Reference Citation Analysis]
234 Peczek L, Zuk K, Stec-Michalska K, Medrek M, Nawrot B. The influence of Helicobacter pylori eradication on the expression and methylation status of the FHIT gene in non-cancerous gastric mucosa of dyspeptic patients. J Dig Dis 2015;16:385-94. [PMID: 25943773 DOI: 10.1111/1751-2980.12252] [Reference Citation Analysis]
235 Hozyasz KK, Mostowska A, Wójcicki P, Lasota A, Offert B, Balcerek A, Dunin-Wilczyńska I, Jagodziński PP. Nucleotide variants of the cancer predisposing gene CDH1 and the risk of non-syndromic cleft lip with or without cleft palate. Fam Cancer 2014;13:415-21. [PMID: 24838934 DOI: 10.1007/s10689-014-9727-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
236 Gurzu S, Jung I, Orlowska J, Sugimura H, Kadar Z, Turdean S, Bara T. Hereditary diffuse gastric cancer--An overview. Pathol Res Pract. 2015;211:629-632. [PMID: 26150395 DOI: 10.1016/j.prp.2015.06.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
237 Sugimoto S, Komatsu H, Morohoshi Y, Kanai T. Recognition of and recent issues in hereditary diffuse gastric cancer. J Gastroenterol. 2015;50:831-843. [PMID: 26049741 DOI: 10.1007/s00535-015-1093-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
238 Benusiglio PR, Colas C, Rouleau E, Uhrhammer N, Romero P, Remenieras A, Moretta J, Wang Q, De Pauw A, Buecher B, Stoppa-Lyonnet D, Mouret-Fourme E, Noguès C, Di Maria M, Tlemsani C, Warcoin M, Grandjouan S, Malka D, Caron O, Blayau M. Hereditary diffuse gastric cancer syndrome: improved performances of the 2015 testing criteria for the identification of probands with a CDH1 germline mutation. J Med Genet 2015;52:563-5. [PMID: 26025002 DOI: 10.1136/jmedgenet-2015-103153] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
239 van der Post RS, Vogelaar IP, Carneiro F, Guilford P, Huntsman D, Hoogerbrugge N, Caldas C, Schreiber KE, Hardwick RH, Ausems MG, Bardram L, Benusiglio PR, Bisseling TM, Blair V, Bleiker E, Boussioutas A, Cats A, Coit D, DeGregorio L, Figueiredo J, Ford JM, Heijkoop E, Hermens R, Humar B, Kaurah P, Keller G, Lai J, Ligtenberg MJ, O'Donovan M, Oliveira C, Pinheiro H, Ragunath K, Rasenberg E, Richardson S, Roviello F, Schackert H, Seruca R, Taylor A, Ter Huurne A, Tischkowitz M, Joe ST, van Dijck B, van Grieken NC, van Hillegersberg R, van Sandick JW, Vehof R, van Krieken JH, Fitzgerald RC. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. J Med Genet. 2015;52:361-374. [PMID: 25979631 DOI: 10.1136/jmedgenet-2015-103094] [Cited by in Crossref: 365] [Cited by in F6Publishing: 387] [Article Influence: 45.6] [Reference Citation Analysis]
240 Lajus TB, Sales RM. CDH1 germ-line missense mutation identified by multigene sequencing in a family with no history of diffuse gastric cancer. Gene 2015;568:215-9. [PMID: 25981591 DOI: 10.1016/j.gene.2015.05.035] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
241 Stoffel EM. Screening in GI Cancers: The Role of Genetics. J Clin Oncol. 2015;33:1721-1728. [PMID: 25918283 DOI: 10.1200/jco.2014.60.6764] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
242 Shah MA. Update on metastatic gastric and esophageal cancers. J Clin Oncol. 2015;33:1760-1769. [PMID: 25918288 DOI: 10.1200/jco.2014.60.1799] [Cited by in Crossref: 132] [Cited by in F6Publishing: 150] [Article Influence: 16.5] [Reference Citation Analysis]
243 Bonadies DC, Brierley KL, Barnett RE, Baxter MD, Donenberg T, Ducaine WL, Ernst ME, Homer J, Judkins M, Lovick NM, Powers JM, Stanislaw C, Stark E, Stenner RC, Matloff ET. Adverse events in cancer genetic testing: the third case series. Cancer J 2014;20:246-53. [PMID: 25098283 DOI: 10.1097/PPO.0000000000000057] [Cited by in Crossref: 32] [Cited by in F6Publishing: 40] [Article Influence: 4.0] [Reference Citation Analysis]
244 Fan M, Hu W, Zhang Z. Chemoradiation for gastric cancer: controversies, updates and novel techniques. Br J Radiol 2015;88:20150027. [PMID: 25827208 DOI: 10.1259/bjr.20150027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
245 Oliveira C, Pinheiro H, Figueiredo J, Seruca R, Carneiro F. Familial gastric cancer: genetic susceptibility, pathology, and implications for management. Lancet Oncol. 2015;16:e60-e70. [PMID: 25638682 DOI: 10.1016/s1470-2045(14)71016-2] [Cited by in Crossref: 219] [Cited by in F6Publishing: 173] [Article Influence: 27.4] [Reference Citation Analysis]
246 Bellizzi AM, Hornick JL. The stomach. Silverberg's Principles and Practice of Surgical Pathology and Cytopathology 2015. [DOI: 10.1017/9781139137201.026] [Reference Citation Analysis]
247 Dossus L, Benusiglio PR. Lobular breast cancer: incidence and genetic and non-genetic risk factors. Breast Cancer Res 2015;17:37. [PMID: 25848941 DOI: 10.1186/s13058-015-0546-7] [Cited by in Crossref: 89] [Cited by in F6Publishing: 98] [Article Influence: 11.1] [Reference Citation Analysis]
248 McFarland D, Miller-Samuel S, Schmidt H, Morris GJ. Case series: five individuals diagnosed with breast and gastrointestinal cancers: are they "related"? Semin Oncol 2015;42:e1-12. [PMID: 25726062 DOI: 10.1053/j.seminoncol.2014.12.016] [Reference Citation Analysis]
249 Abdel-Rahman O. Hedgehog pathway aberrations and gastric cancer; evaluation of prognostic impact and exploration of therapeutic potentials. Tumour Biol 2015;36:1367-74. [PMID: 25680409 DOI: 10.1007/s13277-015-3216-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
250 Bardram L, Hansen TV, Gerdes AM, Timshel S, Friis-Hansen L, Federspiel B. Prophylactic total gastrectomy in hereditary diffuse gastric cancer: identification of two novel CDH1 gene mutations-a clinical observational study. Fam Cancer 2014;13:231-42. [PMID: 24389957 DOI: 10.1007/s10689-013-9698-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
251 Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW; American College of Gastroenterology. ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol 2015;110:223-62; quiz 263. [PMID: 25645574 DOI: 10.1038/ajg.2014.435] [Cited by in Crossref: 957] [Cited by in F6Publishing: 948] [Article Influence: 119.6] [Reference Citation Analysis]
252 Shannon KM, Chittenden A. Breast Cancer Genetics and Risk Assessment. Breast Cancer Screening and Diagnosis 2015. [DOI: 10.1007/978-1-4939-1267-4_1] [Reference Citation Analysis]
253 Prithviraj GK, Almhanna K. Gastric Cancer: Molecular Mechanisms, Diagnosis, and Treatment. International Manual of Oncology Practice 2015. [DOI: 10.1007/978-3-319-21683-6_11] [Reference Citation Analysis]
254 Schattner MA, Wong JCT. Endoscopy and Endoscopic Ultrasound Examination of the Stomach. Gastric Cancer 2015. [DOI: 10.1007/978-3-319-15826-6_9] [Reference Citation Analysis]
255 Carneiro F, Grabsch HI. Pathogenesis of Gastric Cancer. Minimally Invasive Foregut Surgery for Malignancy 2015. [DOI: 10.1007/978-3-319-09342-0_6] [Reference Citation Analysis]
256 Pattison S, Boussioutas A. Pathophysiology of Hereditary Diffuse Gastric Cancer. Gastric Cancer 2015. [DOI: 10.1007/978-3-319-15826-6_6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
257 Daly MB, Forman A. Genetically Based Breast Cancer: Risk Assessment, Counseling, and Testing. Breast Disease 2015. [DOI: 10.1007/978-1-4939-1145-5_9] [Reference Citation Analysis]
258 Economopoulou P, Dimitriadis G, Psyrri A. Beyond BRCA: New hereditary breast cancer susceptibility genes. Cancer Treatment Reviews 2015;41:1-8. [DOI: 10.1016/j.ctrv.2014.10.008] [Cited by in Crossref: 119] [Cited by in F6Publishing: 97] [Article Influence: 14.9] [Reference Citation Analysis]
259 Gurzu S, Kadar Z, Sugimura H, Bara T, Bara T, Halmaciu I, Jung I. Gastric cancer in young vs old Romanian patients: immunoprofile with emphasis on maspin and mena protein reactivity. APMIS. 2015;123:223-233. [PMID: 25556597 DOI: 10.1111/apm.12347] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
260 Carcas LP. Gastric cancer review. J Carcinog. 2014;13:14. [PMID: 25589897 DOI: 10.4103/1477-3163.146506] [Cited by in Crossref: 136] [Cited by in F6Publishing: 157] [Article Influence: 15.1] [Reference Citation Analysis]
261 Abdel-Rahman O. Insulin-like growth factor pathway aberrations and gastric cancer; evaluation of prognostic significance and assessment of therapeutic potentials. Med Oncol. 2015;32:431. [PMID: 25487446 DOI: 10.1007/s12032-014-0431-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
262 Doherty J, Bonadies DC, Matloff ET. Testing for Hereditary Breast Cancer: Panel or Targeted Testing? Experience from a Clinical Cancer Genetics Practice. J Genet Couns 2015;24:683-7. [PMID: 25475920 DOI: 10.1007/s10897-014-9796-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
263 Schneider MR, Kolligs FT. E-cadherin's role in development, tissue homeostasis and disease: Insights from mouse models: Tissue-specific inactivation of the adhesion protein E-cadherin in mice reveals its functions in health and disease. Bioessays 2015;37:294-304. [PMID: 25449798 DOI: 10.1002/bies.201400141] [Cited by in Crossref: 31] [Cited by in F6Publishing: 38] [Article Influence: 3.4] [Reference Citation Analysis]
264 Pinheiro H, Oliveira C, Seruca R, Carneiro F. Hereditary diffuse gastric cancer - pathophysiology and clinical management. Best Pract Res Clin Gastroenterol 2014;28:1055-68. [PMID: 25439071 DOI: 10.1016/j.bpg.2014.09.007] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
265 Choi IJ. Endoscopic gastric cancer screening and surveillance in high-risk groups. Clin Endosc. 2014;47:497-503. [PMID: 25505714 DOI: 10.5946/ce.2014.47.6.497] [Cited by in Crossref: 48] [Cited by in F6Publishing: 54] [Article Influence: 5.3] [Reference Citation Analysis]
266 Rigoli L, Caruso RA. Mitochondrial DNA alterations in the progression of gastric carcinomas: Unexplored issues and future research needs. World J Gastroenterol 2014; 20(43): 16159-16166 [PMID: 25473169 DOI: 10.3748/wjg.v20.i43.16159] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
267 Hampel H, Bennett RL, Buchanan A, Pearlman R, Wiesner GL; Guideline Development Group, American College of Medical Genetics and Genomics Professional Practice and Guidelines Committee and National Society of Genetic Counselors Practice Guidelines Committee. A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment. Genet Med. 2015;17:70-87. [PMID: 25394175 DOI: 10.1038/gim.2014.147] [Cited by in Crossref: 322] [Cited by in F6Publishing: 346] [Article Influence: 35.8] [Reference Citation Analysis]
268 Rich TA, Woodson AH, Litton J, Arun B. Hereditary breast cancer syndromes and genetic testing: Breast Cancer Syndromes and Genetic Testing. J Surg Oncol 2015;111:66-80. [DOI: 10.1002/jso.23791] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
269 King-spohn K, Pilarski R. Beyond BRCA1 and BRCA2. Current Problems in Cancer 2014;38:235-48. [DOI: 10.1016/j.currproblcancer.2014.10.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
270 McLean MH, El-Omar EM. Genetics of gastric cancer. Nat Rev Gastroenterol Hepatol 2014;11:664-74. [PMID: 25134511 DOI: 10.1038/nrgastro.2014.143] [Cited by in Crossref: 250] [Cited by in F6Publishing: 271] [Article Influence: 27.8] [Reference Citation Analysis]
271 Abdel-Rahman O. Targeting the hepatocyte growth factor/mesenchymal epithelial transition pathway in gastric cancer: biological rationale and clinical applications. Expert Rev Anticancer Ther. 2015;15:235-245. [PMID: 25353620 DOI: 10.1586/14737140.2014.974564] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
272 Gaston D, Hansford S, Oliveira C, Nightingale M, Pinheiro H, Macgillivray C, Kaurah P, Rideout AL, Steele P, Soares G, Huang WY, Whitehouse S, Blowers S, LeBlanc MA, Jiang H, Greer W, Samuels ME, Orr A, Fernandez CV, Majewski J, Ludman M, Dyack S, Penney LS, McMaster CR, Huntsman D, Bedard K. Germline mutations in MAP3K6 are associated with familial gastric cancer. PLoS Genet. 2014;10:e1004669. [PMID: 25340522 DOI: 10.1371/journal.pgen.1004669] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 4.7] [Reference Citation Analysis]
273 Corso G, Figueiredo J, Biffi R, Trentin C, Bonanni B, Feroce I, Serrano D, Cassano E, Annibale B, Melo S, Seruca R, De Lorenzi F, Ferrara F, Piagnerelli R, Roviello F, Galimberti V. E-cadherin germline mutation carriers: clinical management and genetic implications. Cancer Metastasis Rev 2014;33:1081-94. [DOI: 10.1007/s10555-014-9528-y] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
274 Yuan D, Chen L, Li M, Xia H, Zhang Y, Chen T, Xia R, Tang Q, Gao F, Mo X, Liu M, Bi F. Isolation and characterization of circulating tumor cells from human gastric cancer patients. J Cancer Res Clin Oncol 2015;141:647-60. [PMID: 25326346 DOI: 10.1007/s00432-014-1814-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
275 Pasechnikov V, Chukov S, Fedorov E, Kikuste I, Leja M. Gastric cancer: Prevention, screening and early diagnosis. World J Gastroenterol 2014; 20(38): 13842-13862 [PMID: 25320521 DOI: 10.3748/wjg.v20.i38.13842] [Cited by in CrossRef: 210] [Cited by in F6Publishing: 230] [Article Influence: 23.3] [Reference Citation Analysis]
276 Zhang L, Xiao A, Ruggeri J, Bacares R, Somar J, Melo S, Figueiredo J, Simões-Correia J, Seruca R, Shah MA. The germline CDH1 c.48 G>C substitution contributes to cancer predisposition through generation of a pro-invasive mutation. Mutat Res 2014;770:106-11. [PMID: 25771876 DOI: 10.1016/j.mrfmmm.2014.10.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
277 Cancer of the oesophagus and stomach. Cancer and its Management 2014. [DOI: 10.1002/9781118468753.ch14] [Reference Citation Analysis]
278 Rainville IR, Rana HQ. Next-generation sequencing for inherited breast cancer risk: counseling through the complexity. Curr Oncol Rep. 2014;16:371. [PMID: 24488544 DOI: 10.1007/s11912-013-0371-z] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 4.7] [Reference Citation Analysis]
279 Nadauld LD, Garcia S, Natsoulis G, Bell JM, Miotke L, Hopmans ES, Xu H, Pai RK, Palm C, Regan JF, Chen H, Flaherty P, Ootani A, Zhang NR, Ford JM, Kuo CJ, Ji HP. Metastatic tumor evolution and organoid modeling implicate TGFBR2 as a cancer driver in diffuse gastric cancer. Genome Biol 2014;15:428. [PMID: 25315765 DOI: 10.1186/s13059-014-0428-9] [Cited by in Crossref: 91] [Cited by in F6Publishing: 95] [Article Influence: 10.1] [Reference Citation Analysis]
280 Choi HJ, Ki CS, Suh SP, Kim JW. Presymptomatic identification of CDH1 germline mutation in a healthy korean individual with family history of gastric cancer. Ann Lab Med 2014;34:386-9. [PMID: 25187893 DOI: 10.3343/alm.2014.34.5.386] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
281 Catenacci DV, Amico AL, Nielsen SM, Geynisman DM, Rambo B, Carey GB, Gulden C, Fackenthal J, Marsh RD, Kindler HL, Olopade OI. Tumor genome analysis includes germline genome: are we ready for surprises? Int J Cancer 2015;136:1559-67. [PMID: 25123297 DOI: 10.1002/ijc.29128] [Cited by in Crossref: 59] [Cited by in F6Publishing: 64] [Article Influence: 6.6] [Reference Citation Analysis]
282 Moreira-Nunes CA, Barros MBL, do Nascimento Borges B, Montenegro RC, Lamarão LM, Ribeiro HF, Bona AB, Assumpção PP, Rey JA, Pinto GR, Burbano RR. Genetic screening analysis of patients with hereditary diffuse gastric cancer from northern and northeastern Brazil. Hered Cancer Clin Pract 2014;12:18. [PMID: 25180051 DOI: 10.1186/1897-4287-12-18] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
283 Liu X, Chu KM. E-cadherin and gastric cancer: cause, consequence, and applications. Biomed Res Int. 2014;2014:637308. [PMID: 25184143 DOI: 10.1155/2014/637308] [Cited by in Crossref: 63] [Cited by in F6Publishing: 83] [Article Influence: 7.0] [Reference Citation Analysis]
284 Worster E, Liu X, Richardson S, Hardwick RH, Dwerryhouse S, Caldas C, Fitzgerald RC. The impact of prophylactic total gastrectomy on health-related quality of life: A prospective cohort study. Ann Surg. 2014;260:87-93. [PMID: 24424140 DOI: 10.1097/sla.0000000000000446] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
285 Valente AL, Rummel S, Shriver CD, Ellsworth RE. Sequence-based detection of mutations in cadherin 1 to determine the prevalence of germline mutations in patients with invasive lobular carcinoma of the breast. Hered Cancer Clin Pract 2014;12:17. [PMID: 25067988 DOI: 10.1186/1897-4287-12-17] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
286 Lim YC, di Pietro M, O'Donovan M, Richardson S, Debiram I, Dwerryhouse S, Hardwick RH, Tischkowitz M, Caldas C, Ragunath K, Fitzgerald RC. Prospective cohort study assessing outcomes of patients from families fulfilling criteria for hereditary diffuse gastric cancer undergoing endoscopic surveillance. Gastrointest Endosc 2014;80:78-87. [PMID: 24472763 DOI: 10.1016/j.gie.2013.11.040] [Cited by in Crossref: 58] [Cited by in F6Publishing: 56] [Article Influence: 6.4] [Reference Citation Analysis]
287 Mandaliya R, Farhat S, Uprety D, Balla M, Gandhi A, Goldhahn R, Auerbach H, Christensen C, Reed C, Cohen S. Occult gastric cancer presenting as hypoxia from pulmonary tumor thrombotic microangiopathy. J Gastric Cancer 2014;14:142-6. [PMID: 25061544 DOI: 10.5230/jgc.2014.14.2.142] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
288 Abdel-Rahman O. Targeting vascular endothelial growth factor (VEGF) pathway in gastric cancer: preclinical and clinical aspects. Crit Rev Oncol Hematol. 2015;93:18-27. [PMID: 24970311 DOI: 10.1016/j.critrevonc.2014.05.012] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 4.4] [Reference Citation Analysis]
289 Carneiro F, Wen X, Seruca R, Oliveira C. Familial gastric carcinoma. Diagnostic Histopathology 2014;20:239-46. [DOI: 10.1016/j.mpdhp.2014.03.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
290 Kim S, Chung JW, Jeong TD, Park YS, Lee JH, Ahn JY, Kim DH, Choi KD, Lee W, Song HJ, Lee GH, Chun S, Jung HY, Min WK, Kim JH. Searching for E-cadherin gene mutations in early onset diffuse gastric cancer and hereditary diffuse gastric cancer in Korean patients. Fam Cancer 2013;12:503-7. [PMID: 23264079 DOI: 10.1007/s10689-012-9595-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
291 Waddell T, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D; European Society for Medical Oncology (ESMO)., European Society of Surgical Oncology (ESSO)., European Society of Radiotherapy and Oncology (ESTRO). Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013;24 Suppl 6:vi57-63. [PMID: 24078663 DOI: 10.1093/annonc/mdt344] [Cited by in Crossref: 196] [Cited by in F6Publishing: 227] [Article Influence: 21.8] [Reference Citation Analysis]
292 Waddell T, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D; European Society for Medical Oncology (ESMO); European Society of Surgical Oncology (ESSO); European Society of Radiotherapy and Oncology (ESTRO). Gastric cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Eur J Surg Oncol. 2014;40:584-591. [PMID: 24685156 DOI: 10.1016/j.ejso.2013.09.020] [Cited by in Crossref: 116] [Cited by in F6Publishing: 136] [Article Influence: 12.9] [Reference Citation Analysis]
293 Gurgel DC, Valença-Junior JT, Dornelas CA, Vieira RB, Maia-Filho JT, Lima-Junior RC, Ribeiro RA, Almeida PR. Immunoexpression of metalloproteinases 2 and 14 and TIMP-2 inhibitor in main types of primary gastric carcinomas and lymph node metastasis. Pathol Oncol Res 2015;21:73-81. [PMID: 24800696 DOI: 10.1007/s12253-014-9790-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
294 Downes MR, Allo G, McCluggage WG, Sy K, Ferguson SE, Aronson M, Pollett A, Gallinger S, Bilbily E, Shaw P, Clarke BA. Review of findings in prophylactic gynaecological specimens in Lynch syndrome with literature review and recommendations for grossing. Histopathology 2014;65:228-39. [PMID: 24495259 DOI: 10.1111/his.12386] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
295 van der Post RS, Bult P, Vogelaar IP, Ligtenberg MJ, Hoogerbrugge N, van Krieken JH. HNF4A immunohistochemistry facilitates distinction between primary and metastatic breast and gastric carcinoma. Virchows Arch. 2014;464:673-679. [PMID: 24711169 DOI: 10.1007/s00428-014-1574-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
296 Cragun D, Radford C, Dolinsky JS, Caldwell M, Chao E, Pal T. Panel-based testing for inherited colorectal cancer: a descriptive study of clinical testing performed by a US laboratory. Clin Genet 2014;86:510-20. [PMID: 24506336 DOI: 10.1111/cge.12359] [Cited by in Crossref: 76] [Cited by in F6Publishing: 80] [Article Influence: 8.4] [Reference Citation Analysis]
297 Lordick F, Allum W, Carneiro F, Mitry E, Tabernero J, Tan P, Van Cutsem E, van de Velde C, Cervantes A. Unmet needs and challenges in gastric cancer: the way forward. Cancer Treat Rev. 2014;40:692-700. [PMID: 24656602 DOI: 10.1016/j.ctrv.2014.03.002] [Cited by in Crossref: 126] [Cited by in F6Publishing: 134] [Article Influence: 14.0] [Reference Citation Analysis]
298 Wei Z, Guo W, Wu J, Suo W, Fu G. A nonsense mutation in the Xeroderma pigmentosum complementation group F (XPF) gene is associated with gastric carcinogenesis. Gene 2014;537:238-44. [DOI: 10.1016/j.gene.2013.12.061] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
299 Gonçalves A, Moretta J, Eisinger F, Bertucci F. [Personalized medicine and breast cancer: anticipatory medicine, prognostic evaluation and therapeutic targeting]. Bull Cancer 2013;100:1295-310. [PMID: 24225763 DOI: 10.1684/bdc.2013.1856] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
300 Molinaro V, Pensotti V, Marabelli M, Feroce I, Barile M, Pozzi S, Laghi L, Serrano D, Bernard L, Bonanni B, Ranzani GN. Complementary molecular approaches reveal heterogeneous CDH1 germline defects in Italian patients with hereditary diffuse gastric cancer (HDGC) syndrome. Genes Chromosomes Cancer 2014;53:432-45. [PMID: 24493355 DOI: 10.1002/gcc.22155] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
301 Boda T, Ito M, Yoshihara M, Kitamura Y, Matsuo T, Oka S, Tanaka S, Chayama K. Advanced method for evaluation of gastric cancer risk by serum markers: determination of true low-risk subjects for gastric neoplasm. Helicobacter 2014;19:1-8. [PMID: 24215601 DOI: 10.1111/hel.12101] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
302 Bordeira-Carriço R, Ferreira D, Mateus DD, Pinheiro H, Pêgo AP, Santos MA, Oliveira C. Rescue of wild-type E-cadherin expression from nonsense-mutated cancer cells by a suppressor-tRNA. Eur J Hum Genet 2014;22:1085-92. [PMID: 24424122 DOI: 10.1038/ejhg.2013.292] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
303 Lauwers GY, Mullen JT, Chelcun Schreiber KE, Chung DC. Familial Gastric Cancers. Pathology Case Reviews 2014;19:66-73. [DOI: 10.1097/pcr.0000000000000030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
304 Arnold M, Moore SP, Hassler S, Ellison-Loschmann L, Forman D, Bray F. The burden of stomach cancer in indigenous populations: a systematic review and global assessment. Gut 2014;63:64-71. [PMID: 24153248 DOI: 10.1136/gutjnl-2013-305033] [Cited by in Crossref: 74] [Cited by in F6Publishing: 82] [Article Influence: 8.2] [Reference Citation Analysis]
305 Waddell T, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D. Gastric cancer†: ESMO–ESSO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Radiotherapy and Oncology 2014;110:189-94. [DOI: 10.1016/j.radonc.2013.09.015] [Cited by in Crossref: 18] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
306 Ravi K, Sweetser S. Persistent nausea and vomiting in pregnancy. Gastroenterology 2014;146:33, 323. [PMID: 24269302 DOI: 10.1053/j.gastro.2013.09.003] [Reference Citation Analysis]
307 Schrader KA, Sharaf R, Alanee S, Offit K. Genetic Factors. Abeloff's Clinical Oncology 2014. [DOI: 10.1016/b978-1-4557-2865-7.00012-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
308 Grin A, Jothy S. Molecular Pathology of Gastrointestinal Tumors. Molecular Testing in Cancer 2014. [DOI: 10.1007/978-1-4899-8050-2_12] [Reference Citation Analysis]
309 Hodgson SV, Foulkes WD, Eng C, Maher ER. Gastrointestinal System. A Practical Guide to Human Cancer Genetics 2014. [DOI: 10.1007/978-1-4471-2375-0_5] [Reference Citation Analysis]
310 Carneiro F. Gastric Cancer. Pathobiology of Human Disease 2014. [DOI: 10.1016/b978-0-12-386456-7.03808-9] [Reference Citation Analysis]
311 Heitzer E, Lax S, Lafer I, Müller SM, Pristauz G, Ulz P, Jahn S, Högenauer C, Petru E, Speicher MR, Geigl JB. Multiplex genetic cancer testing identifies pathogenic mutations in TP53 and CDH1 in a patient with bilateral breast and endometrial adenocarcinoma. BMC Med Genet 2013;14:129. [PMID: 24373500 DOI: 10.1186/1471-2350-14-129] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
312 Petridis C, Shinomiya I, Kohut K, Gorman P, Caneppele M, Shah V, Troy M, Pinder SE, Hanby A, Tomlinson I, Trembath RC, Roylance R, Simpson MA, Sawyer EJ. Germline CDH1 mutations in bilateral lobular carcinoma in situ. Br J Cancer. 2014;110:1053-1057. [PMID: 24366306 DOI: 10.1038/bjc.2013.792] [Cited by in Crossref: 55] [Cited by in F6Publishing: 59] [Article Influence: 5.5] [Reference Citation Analysis]
313 Schiano C, Casamassimi A, Rienzo M, de Nigris F, Sommese L, Napoli C. Involvement of Mediator complex in malignancy. Biochim Biophys Acta 2014;1845:66-83. [PMID: 24342527 DOI: 10.1016/j.bbcan.2013.12.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 59] [Article Influence: 2.4] [Reference Citation Analysis]
314 Yiannakopoulou E. Etiology of familial breast cancer with undetected BRCA1 and BRCA2 mutations: clinical implications. Cell Oncol (Dordr) 2014;37:1-8. [PMID: 24306927 DOI: 10.1007/s13402-013-0158-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
315 Bellizzi AM. Contributions of molecular analysis to the diagnosis and treatment of gastrointestinal neoplasms. Seminars in Diagnostic Pathology 2013;30:329-61. [DOI: 10.1053/j.semdp.2013.11.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
316 Garziera M, Canzonieri V, Cannizzaro R, Geremia S, Caggiari L, De Zorzi M, Maiero S, Orzes E, Perin T, Zanussi S, De Paoli P, De Re V. Identification and characterization of CDH1 germline variants in sporadic gastric cancer patients and in individuals at risk of gastric cancer. PLoS One 2013;8:e77035. [PMID: 24204729 DOI: 10.1371/journal.pone.0077035] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
317 Gronnier C, Messager M, Robb WB, Thiebot T, Louis D, Luc G, Piessen G, Mariette C. Is the negative prognostic impact of signet ring cell histology maintained in early gastric adenocarcinoma? Surgery. 2013;154:1093-1099. [PMID: 24075273 DOI: 10.1016/j.surg.2013.05.020] [Cited by in Crossref: 44] [Cited by in F6Publishing: 52] [Article Influence: 4.4] [Reference Citation Analysis]
318 Yamada M, Fukagawa T, Nakajima T, Asada K, Sekine S, Yamashita S, Okochi-Takada E, Taniguchi H, Kushima R, Oda I, Saito Y, Ushijima T, Katai H. Hereditary diffuse gastric cancer in a Japanese family with a large deletion involving CDH1. Gastric Cancer. 2014;17:750-756. [PMID: 24037103 DOI: 10.1007/s10120-013-0298-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
319 Yu J, Fu B, Zhao Q. Family history of malignant neoplasm and its relation with clinicopathologic features of gastric cancer patients. World J Surg Oncol 2013;11:201. [PMID: 23953708 DOI: 10.1186/1477-7819-11-201] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
320 Evans DG, Ingham SL. Reduced life expectancy seen in hereditary diseases which predispose to early-onset tumors. Appl Clin Genet 2013;6:53-61. [PMID: 23935382 DOI: 10.2147/TACG.S35605] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
321 Yuan Y. A survey and evaluation of population-based screening for gastric cancer. Cancer Biol Med. 2013;10:72-80. [PMID: 23882421 DOI: 10.7497/j.issn.2095-3941.2013.02.002] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
322 Banks KC, Moline JJ, Marvin ML, Newlin AC, Vogel KJ. 10 rare tumors that warrant a genetics referral. Fam Cancer 2013;12:1-18. [PMID: 23377869 DOI: 10.1007/s10689-012-9584-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
323 Grabsch HI, Tan P. Gastric cancer pathology and underlying molecular mechanisms. Dig Surg 2013;30:150-8. [PMID: 23867592 DOI: 10.1159/000350876] [Cited by in Crossref: 68] [Cited by in F6Publishing: 71] [Article Influence: 6.8] [Reference Citation Analysis]
324 Hamilton LE, Jones K, Church N, Medlicott S. Synchronous appendiceal and intramucosal gastric signet ring cell carcinomas in an individual with CDH1-associated hereditary diffuse gastric carcinoma: a case report of a novel association and review of the literature. BMC Gastroenterol. 2013;13:114. [PMID: 23849133 DOI: 10.1186/1471-230x-13-114] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
325 Maxwell KN, Domchek SM. Familial Breast Cancer Risk. Curr Breast Cancer Rep 2013;5:170-82. [DOI: 10.1007/s12609-013-0117-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
326 Spier I, Holzapfel S, Steinke V, Aretz S. Genetik gastrointestinaler Tumoren. Gastroenterologe 2013;8:303-315. [DOI: 10.1007/s11377-013-0764-4] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
327 Sugimoto S, Yamada H, Takahashi M, Morohoshi Y, Yamaguchi N, Tsunoda Y, Hayashi H, Sugimura H, Komatsu H. Early-onset diffuse gastric cancer associated with a de novo large genomic deletion of CDH1 gene. Gastric Cancer. 2014;17:745-749. [PMID: 23812922 DOI: 10.1007/s10120-013-0278-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
328 Carneiro F. Hereditary gastric cancer. Pathologe. 2012;33 Suppl 2:231-234. [PMID: 23052347 DOI: 10.1007/s00292-012-1677-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
329 Uppal DS, Powell SM. Genetics/genomics/proteomics of gastric adenocarcinoma. Gastroenterol Clin North Am 2013;42:241-60. [PMID: 23639639 DOI: 10.1016/j.gtc.2013.01.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
330 de Martel C, Forman D, Plummer M. Gastric cancer: epidemiology and risk factors. Gastroenterol Clin North Am 2013;42:219-40. [PMID: 23639638 DOI: 10.1016/j.gtc.2013.01.003] [Cited by in Crossref: 253] [Cited by in F6Publishing: 254] [Article Influence: 25.3] [Reference Citation Analysis]
331 Yakirevich E, Resnick MB. Pathology of gastric cancer and its precursor lesions. Gastroenterol Clin North Am 2013;42:261-84. [PMID: 23639640 DOI: 10.1016/j.gtc.2013.01.004] [Cited by in Crossref: 96] [Cited by in F6Publishing: 100] [Article Influence: 9.6] [Reference Citation Analysis]
332 Niendorf KB, Thomas BC. Genetic Counseling for Cancer: Technology Promises Better Screening for Hereditary Cancer Patients. Curr Genet Med Rep 2013;1:135-141. [DOI: 10.1007/s40142-013-0015-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
333 Benusiglio PR, Malka D, Rouleau E, De Pauw A, Buecher B, Noguès C, Fourme E, Colas C, Coulet F, Warcoin M, Grandjouan S, Sezeur A, Laurent-puig P, Molière D, Tlemsani C, Di Maria M, Byrde V, Delaloge S, Blayau M, Caron O. CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study. J Med Genet 2013;50:486-9. [DOI: 10.1136/jmedgenet-2012-101472] [Cited by in Crossref: 108] [Cited by in F6Publishing: 113] [Article Influence: 10.8] [Reference Citation Analysis]
334 Kluijt I, Sijmons RH, Hoogerbrugge N, Plukker JT, de Jong D, van Krieken JH, van Hillegersberg R, Ligtenberg M, Bleiker E, Cats A; Dutch Working Group on Hereditary Gastric Cancer. Familial gastric cancer: guidelines for diagnosis, treatment and periodic surveillance. Fam Cancer. 2012;11:363-369. [PMID: 22388873 DOI: 10.1007/s10689-012-9521-y] [Cited by in Crossref: 59] [Cited by in F6Publishing: 50] [Article Influence: 5.9] [Reference Citation Analysis]
335 Liu WZ, Xie Y, Cheng H, Lu NH, Hu FL, Zhang WD, Zhou LY, Chen Y, Zeng ZR, Wang CW, Xiao SD, Pan GZ, Hu PJ; Chinese Society of Gastroenterology, Chinese Study Group on Helicobacter pylori. Fourth Chinese National Consensus Report on the management of Helicobacter pylori infection. J Dig Dis 2013;14:211-21. [PMID: 23302262 DOI: 10.1111/1751-2980.12034] [Cited by in Crossref: 85] [Cited by in F6Publishing: 92] [Article Influence: 8.5] [Reference Citation Analysis]
336 Raymond VM, Stoffel EM. Familial Gastric and Pancreatic Cancers: Diagnosis and Screening. American Society of Clinical Oncology Educational Book 2013. [DOI: 10.14694/edbook_am.2013.33.e44] [Reference Citation Analysis]
337 Majewski IJ, Kluijt I, Cats A, Scerri TS, de Jong D, Kluin RJ, Hansford S, Hogervorst FB, Bosma AJ, Hofland I. An α-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancer. J Pathol. 2013;229:621-629. [PMID: 23208944 DOI: 10.1002/path.4152] [Cited by in Crossref: 138] [Cited by in F6Publishing: 145] [Article Influence: 13.8] [Reference Citation Analysis]
338 Euhus DM, Robinson L. Genetic Predisposition Syndromes and Their Management. Surgical Clinics of North America 2013;93:341-62. [DOI: 10.1016/j.suc.2013.01.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
339 Abrams JA, Gonsalves L, Neugut AI. Diverging trends in the incidence of reflux-related and Helicobacter pylori-related gastric cardia cancer. J Clin Gastroenterol 2013;47:322-7. [PMID: 22914345 DOI: 10.1097/MCG.0b013e318260177a] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
340 Domchek SM, Bradbury A, Garber JE, Offit K, Robson ME. Multiplex genetic testing for cancer susceptibility: out on the high wire without a net? J Clin Oncol. 2013;31:1267-1270. [PMID: 23460708 DOI: 10.1200/jco.2012.46.9403] [Cited by in Crossref: 171] [Cited by in F6Publishing: 194] [Article Influence: 17.1] [Reference Citation Analysis]
341 Oliveira C, Seruca R, Hoogerbrugge N, Ligtenberg M, Carneiro F. Clinical utility gene card for: Hereditary diffuse gastric cancer (HDGC). Eur J Hum Genet. 2013;21. [PMID: 23443028 DOI: 10.1038/ejhg.2012.247] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
342 Chun N, Ford JM. Genetic testing by cancer site: stomach. Cancer J. 2012;18:355-363. [PMID: 22846738 DOI: 10.1097/ppo.0b013e31826246dc] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 5.3] [Reference Citation Analysis]
343 Corso G, Carvalho J, Marrelli D, Vindigni C, Carvalho B, Seruca R, Roviello F, Oliveira C. Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer. J Clin Oncol. 2013;31:868-875. [PMID: 23341533 DOI: 10.1200/jco.2012.44.4612] [Cited by in Crossref: 123] [Cited by in F6Publishing: 134] [Article Influence: 12.3] [Reference Citation Analysis]
344 Fujita H, Lennerz JK, Chung DC, Patel D, Deshpande V, Yoon SS, Lauwers GY. Endoscopic surveillance of patients with hereditary diffuse gastric cancer: Biopsy recommendations after topographic distribution of cancer foci in a series of 10 CDH1-mutated gastrectomies. Am J Surg Pathol. 2012;36:1709-1717. [PMID: 23073328 DOI: 10.1097/pas.0b013e31826ca204] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 5.3] [Reference Citation Analysis]
345 Shulman LP. Genetic and Genomic Factors in Breast Cancer. Management of the Patient at High Risk for Breast Cancer 2013. [DOI: 10.1007/978-1-4614-5891-3_2] [Reference Citation Analysis]
346 Carvalho J, Pinheiro H, Oliveira C. E-Cadherin Germline Mutations. Spotlight on Familial and Hereditary Gastric Cancer 2013. [DOI: 10.1007/978-94-007-6570-2_5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
347 Corso G, Marrelli D. Frequency of Familial Gastric Cancer. Spotlight on Familial and Hereditary Gastric Cancer 2013. [DOI: 10.1007/978-94-007-6570-2_2] [Reference Citation Analysis]
348 Miller ME, Nielsen SM, Kulkarni SA. Management of Concomitant Risk. Management of the Patient at High Risk for Breast Cancer 2013. [DOI: 10.1007/978-1-4614-5891-3_10] [Reference Citation Analysis]
349 Keller G. Hereditary Diffuse Gastric Cancer and Lobular Breast Carcinoma. Spotlight on Familial and Hereditary Gastric Cancer 2013. [DOI: 10.1007/978-94-007-6570-2_11] [Reference Citation Analysis]
350 Corso G, Marrelli D, Roviello F. Clinical Management of Familial Gastric Cancer. Spotlight on Familial and Hereditary Gastric Cancer 2013. [DOI: 10.1007/978-94-007-6570-2_16] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
351 Ferrara F, Corso G, Roviello F. Prophylactic Total Gastrectomy in CDH1 Germline Mutation Carriers. Spotlight on Familial and Hereditary Gastric Cancer 2013. [DOI: 10.1007/978-94-007-6570-2_14] [Reference Citation Analysis]
352 Odegaard JI, Schrijver I. Molecular Pathology of Hereditary Diffuse Gastric Cancer. JCT 2013;04:554-561. [DOI: 10.4236/jct.2013.42070] [Reference Citation Analysis]
353 Carneiro F, Oliveira C, Seruca R. Hereditary Diffuse Gastric Cancer and Other Gastric Cancers Associated with Hereditary Predisposition Syndromes. Molecular Pathology Library 2013. [DOI: 10.1007/978-1-4614-6015-2_6] [Reference Citation Analysis]
354 Carneiro F. Pathology of Hereditary Gastric Cancer. Spotlight on Familial and Hereditary Gastric Cancer 2013. [DOI: 10.1007/978-94-007-6570-2_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
355 De Falco G, Videtta AD. Clinical Criteria for Familial Gastric Cancer Definition. Spotlight on Familial and Hereditary Gastric Cancer 2013. [DOI: 10.1007/978-94-007-6570-2_13] [Reference Citation Analysis]
356 Corso G. Appendix. Spotlight on Familial and Hereditary Gastric Cancer 2013. [DOI: 10.1007/978-94-007-6570-2_17] [Reference Citation Analysis]
357 Oliveira C, Pinheiro H, Figueiredo J, Seruca R, Carneiro F. E-cadherin alterations in hereditary disorders with emphasis on hereditary diffuse gastric cancer. Prog Mol Biol Transl Sci 2013;116:337-59. [PMID: 23481202 DOI: 10.1016/B978-0-12-394311-8.00015-7] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 4.5] [Reference Citation Analysis]
358 Leite M, Corso G, Sousa S, Carvalho J, Roviello F, Oliveira C, Figueiredo C, Seruca R. Non-CDH1-Associated Familial Gastric Cancer and Epigenetics Factors. Spotlight on Familial and Hereditary Gastric Cancer 2013. [DOI: 10.1007/978-94-007-6570-2_10] [Reference Citation Analysis]
359 Corso G, Roncalli F, Marrelli D, Carneiro F, Roviello F. History, pathogenesis, and management of familial gastric cancer: original study of John XXIII's family. Biomed Res Int 2013;2013:385132. [PMID: 23484115 DOI: 10.1155/2013/385132] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
360 Blair V, Kahokehr A, Sammour T. Cancer in Māori: lessons from prostate, colorectal and gastric cancer and progress in hereditary stomach cancer in New Zealand: Prostate, colon and gastric cancer in Māori. ANZ J Surg 2013;83:42-8. [DOI: 10.1111/ans.12042] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
361 Vogelaar IP, van der Post RS, Bisseling TM, van Krieken JHJ, Ligtenberg MJ, Hoogerbrugge N. Familial gastric cancer: detection of a hereditary cause helps to understand its etiology. Hered Cancer Clin Pract 2012;10:18. [PMID: 23231819 DOI: 10.1186/1897-4287-10-18] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
362 Carneiro F, Lauwers GY. Epithelial Tumours of the Stomach. Morson and Dawson's Gastrointestinal Pathology 2012. [DOI: 10.1002/9781118399668.ch13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
363 Vogelaar IP, Figueiredo J, van Rooij IA, Simões-Correia J, van der Post RS, Melo S, Seruca R, Carels CE, Ligtenberg MJ, Hoogerbrugge N. Identification of germline mutations in the cancer predisposing gene CDH1 in patients with orofacial clefts. Hum Mol Genet 2013;22:919-26. [PMID: 23197654 DOI: 10.1093/hmg/dds497] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 4.1] [Reference Citation Analysis]
364 Benusiglio PR, Caron O, Consolino E, Duvillard P, Coulet F, Blayau M, Malka D. Cleft lip, cleft palate, hereditary diffuse gastric cancer and germline mutations in CDH1. Int J Cancer 2013;132:2470. [PMID: 23124477 DOI: 10.1002/ijc.27923] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
365 Bystricky B, Cunningham D. Gastric Cancer. Handbook of Gastrointestinal Cancer 2012. [DOI: 10.1002/9781118423318.ch3] [Reference Citation Analysis]
366 Guggenheim DE, Shah MA. Gastric cancer epidemiology and risk factors. J Surg Oncol. 2013;107:230-236. [PMID: 23129495 DOI: 10.1002/jso.23262] [Cited by in Crossref: 296] [Cited by in F6Publishing: 330] [Article Influence: 26.9] [Reference Citation Analysis]
367 Bordeira-Carriço R, Pêgo AP, Santos M, Oliveira C. Cancer syndromes and therapy by stop-codon readthrough. Trends Mol Med 2012;18:667-78. [PMID: 23044248 DOI: 10.1016/j.molmed.2012.09.004] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 4.5] [Reference Citation Analysis]
368 Chang VY, Federman N, Martinez-Agosto J, Tatishchev SF, Nelson SF. Whole exome sequencing of pediatric gastric adenocarcinoma reveals an atypical presentation of Li-Fraumeni syndrome. Pediatr Blood Cancer. 2013;60:570-574. [PMID: 23015295 DOI: 10.1002/pbc.24316] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
369 Giordano A, Cito L. Advances in gastric cancer prevention. World J Clin Oncol 2012; 3(9): 128-136 [PMID: 23061031 DOI: 10.5306/wjco.v3.i9.128] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
370 Hu B, El Hajj N, Sittler S, Lammert N, Barnes R, Meloni-Ehrig A. Gastric cancer: Classification, histology and application of molecular pathology. J Gastrointest Oncol. 2012;3:251-261. [PMID: 22943016 DOI: 10.3978/j.issn.2078-6891.2012.021] [Cited by in F6Publishing: 206] [Reference Citation Analysis]
371 Salo-mullen EE, Guillem JG. The Genetic Counselor. Advances in Surgery 2012;46:137-53. [DOI: 10.1016/j.yasu.2012.03.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
372 Dixon M, Seevaratnam R, Wirtzfeld D, Mcleod R, Helyer L, Law C, Swallow C, Paszat L, Bocicariu A, Cardoso R, Mahar A, Bekaii-saab T, Chau I, Church N, Coit D, Crane CH, Earle C, Mansfield P, Marcon N, Miner T, Noh SH, Porter G, Posner MC, Prachand V, Sano T, Van de Velde CJH, Wong S, Coburn N. A RAND/UCLA Appropriateness Study of the Management of Familial Gastric Cancer. Ann Surg Oncol 2013;20:533-41. [DOI: 10.1245/s10434-012-2584-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
373 Tang W, Morgan DR, Meyers MO, Dominguez RL, Martinez E, Kakudo K, Kuan PF, Banet N, Muallem H, Woodward K. Epstein-barr virus infected gastric adenocarcinoma expresses latent and lytic viral transcripts and has a distinct human gene expression profile. Infect Agent Cancer. 2012;7:21. [PMID: 22929309 DOI: 10.1186/1750-9378-7-21] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 4.1] [Reference Citation Analysis]
374 Dikken JL, van de Velde CJ, Coit DG, Shah MA, Verheij M, Cats A. Treatment of resectable gastric cancer. Therap Adv Gastroenterol. 2012;5:49-69. [PMID: 22282708 DOI: 10.1177/1756283x11410771] [Cited by in Crossref: 52] [Cited by in F6Publishing: 57] [Article Influence: 4.7] [Reference Citation Analysis]
375 Carneiro P, Fernandes MS, Figueiredo J, Caldeira J, Carvalho J, Pinheiro H, Leite M, Melo S, Oliveira P, Simões-Correia J, Oliveira MJ, Carneiro F, Figueiredo C, Paredes J, Oliveira C, Seruca R. E-cadherin dysfunction in gastric cancer--cellular consequences, clinical applications and open questions. FEBS Lett 2012;586:2981-9. [PMID: 22841718 DOI: 10.1016/j.febslet.2012.07.045] [Cited by in Crossref: 64] [Cited by in F6Publishing: 72] [Article Influence: 5.8] [Reference Citation Analysis]
376 Stadler ZK, Salo-Mullen E, Zhang L, Shia J, Bacares R, Power DG, Weiser M, Coit D, Robson ME, Offit K. Juvenile polyposis syndrome presenting with familial gastric cancer and massive gastric polyposis. J Clin Oncol. 2012;30:e229-e232. [PMID: 22826269 DOI: 10.1200/jco.2012.41.7949] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
377 Johnston JJ, Rubinstein WS, Facio FM, Ng D, Singh LN, Teer JK, Mullikin JC, Biesecker LG. Secondary variants in individuals undergoing exome sequencing: screening of 572 individuals identifies high-penetrance mutations in cancer-susceptibility genes. Am J Hum Genet 2012;91:97-108. [PMID: 22703879 DOI: 10.1016/j.ajhg.2012.05.021] [Cited by in Crossref: 157] [Cited by in F6Publishing: 157] [Article Influence: 14.3] [Reference Citation Analysis]
378 Marcos-Pinto R, Dinis-Ribeiro M, Carneiro F, Machado JC, Figueiredo C, Reis CA, Ferreira J, Areias J. First degree relatives and familial aggregation of gastric cancer: who to choose for control in case-control studies? Fam Cancer 2012;11:137-43. [PMID: 22057474 DOI: 10.1007/s10689-011-9488-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
379 Shannon KM, Chittenden A. Genetic Testing by Cancer Site: Breast. The Cancer Journal 2012;18:310-9. [DOI: 10.1097/ppo.0b013e318260946f] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
380 Barr H, Almond M. The future developments in upper GI cancer. Frontline Gastroenterol 2012;3:i24-7. [PMID: 28839688 DOI: 10.1136/flgastro-2012-100113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
381 Onitilo AA, Aryal G, Engel JM. Hereditary diffuse gastric cancer: a family diagnosis and treatment. Clin Med Res. 2013;11:36-41. [PMID: 22723466 DOI: 10.3121/cmr.2012.1071] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
382 Leja M, Wex T, Malfertheiner P. Markers for gastric cancer premalignant lesions: where do we go? Dig Dis 2012;30:268-76. [PMID: 22722551 DOI: 10.1159/000336990] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
383 Daunton A, Puig S, Taniere P, Forde C, Alderson D, Tucker O. Prevention is better than cure. J Surg Case Rep 2012;2012:14. [PMID: 24960683 DOI: 10.1093/jscr/2012.6.14] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
384 Mester J, Eng C. Estimate of de novo mutation frequency in probands with PTEN hamartoma tumor syndrome. Genet Med 2012;14:819-22. [PMID: 22595938 DOI: 10.1038/gim.2012.51] [Cited by in Crossref: 55] [Cited by in F6Publishing: 59] [Article Influence: 5.0] [Reference Citation Analysis]
385 Palka Bayard de Volo C, Alfonsi M, Gatta V, Novelli A, Bernardini L, Fantasia D, Antonucci I, Angelucci D, Zori R, Stuppia L, Chiarelli F, Calabrese G. 16q22.1 microdeletion detected by array-CGH in a family with mental retardation and lobular breast cancer. Gene 2012;498:328-31. [DOI: 10.1016/j.gene.2012.01.028] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
386 Garziera M, De Re V, Geremia S, Seruca R, Figueiredo J, Melo S, Simões-Correia J, Caggiari L, De Zorzi M, Canzonieri V, Cannizzaro R, Toffoli G. A novel CDH1 germline missense mutation in a sporadic gastric cancer patient in north-east of Italy. Clin Exp Med 2013;13:149-57. [PMID: 22543498 DOI: 10.1007/s10238-012-0184-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
387 Blair VR. Familial gastric cancer: genetics, diagnosis, and management. Surg Oncol Clin N Am 2012;21:35-56. [PMID: 22098830 DOI: 10.1016/j.soc.2011.09.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
388 Popa E, Schnoll‐sussman F, Jesudian A, Nandakumar G, Shah MA. Uncommon Cancers of the Stomach. Textbook of Uncommon Cancer 2012. [DOI: 10.1002/9781118464557.ch28] [Reference Citation Analysis]
389 Corso G, Marrelli D, Pascale V, Vindigni C, Roviello F. Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: metanalysis and systematic review of the literature. BMC Cancer. 2012;12:8. [PMID: 22225527 DOI: 10.1186/1471-2407-12-8] [Cited by in Crossref: 65] [Cited by in F6Publishing: 70] [Article Influence: 5.9] [Reference Citation Analysis]
390 Sereno M, Aguayo C, Guillén Ponce C, Gómez-Raposo C, Zambrana F, Gómez-López M, Casado E. Gastric tumours in hereditary cancer syndromes: clinical features, molecular biology and strategies for prevention. Clin Transl Oncol. 2011;13:599-610. [PMID: 21865131 DOI: 10.1007/s12094-011-0705-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
391 Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, Monteiro-Soares M, O'Connor A, Pereira C, Pimentel-Nunes P, Correia R, Ensari A, Dumonceau JM, Machado JC, Macedo G, Malfertheiner P, Matysiak-Budnik T, Megraud F, Miki K, O'Morain C, Peek RM, Ponchon T, Ristimaki A, Rembacken B, Carneiro F, Kuipers EJ; European Society of Gastrointestinal Endoscopy, European Helicobacter Study Group, European Society of Pathology, Sociedade Portuguesa de Endoscopia Digestiva. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012;44:74-94. [PMID: 22198778 DOI: 10.1055/s-0031-1291491] [Cited by in Crossref: 436] [Cited by in F6Publishing: 422] [Article Influence: 39.6] [Reference Citation Analysis]
392 Dinis-ribeiro M, Areia M, de Vries AC, Marcos-pinto R, Monteiro-soares M, O’connor A, Pereira C, Pimentel-nunes P, Correia R, Ensari A, Dumonceau JM, Machado JC, Macedo G, Malfertheiner P, Matysiak-budnik T, Megraud F, Miki K, O’morain C, Peek RM, Ponchon T, Ristimaki A, Rembacken B, Carneiro F, Kuipers EJ; on behalf of MAPS Participants. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Virchows Arch 2012;460:19-46. [DOI: 10.1007/s00428-011-1177-8] [Cited by in Crossref: 59] [Cited by in F6Publishing: 91] [Article Influence: 4.9] [Reference Citation Analysis]
393 Seevaratnam R, Coburn N, Cardoso R, Dixon M, Bocicariu A, Helyer L. A systematic review of the indications for genetic testing and prophylactic gastrectomy among patients with hereditary diffuse gastric cancer. Gastric Cancer. 2012;15 Suppl 1:S153-S163. [PMID: 22160243 DOI: 10.1007/s10120-011-0116-3] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 3.8] [Reference Citation Analysis]
394 Patel SH, Kooby DA. Gastric adenocarcinoma surgery and adjuvant therapy. Surg Clin North Am 2011;91:1039-77. [PMID: 21889029 DOI: 10.1016/j.suc.2011.06.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
395 Kluijt I, Siemerink EJ, Ausems MG, van Os TA, de Jong D, Simões-Correia J, van Krieken JH, Ligtenberg MJ, Figueiredo J, van Riel E, Sijmons RH, Plukker JT, van Hillegersberg R, Dekker E, Oliveira C, Cats A, Hoogerbrugge N; Dutch Working Group on Hereditary Gastric Cancer. CDH1-related hereditary diffuse gastric cancer syndrome: clinical variations and implications for counseling. Int J Cancer 2012;131:367-76. [PMID: 22020549 DOI: 10.1002/ijc.26398] [Cited by in Crossref: 85] [Cited by in F6Publishing: 91] [Article Influence: 7.1] [Reference Citation Analysis]
396 Zuk K, Peczek L, Stec-Michalska K, Medrek M, Nawrot B. Family history of gastric cancer correlates with decreased expression of HINT1 tumor suppressor gene in gastric mucosa of dyspeptic patients. Oncol Lett 2012;3:219-23. [PMID: 22740884 DOI: 10.3892/ol.2011.456] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
397 Corso G, Marrelli D, Roviello F. Familial gastric cancer: update for practice management. Fam Cancer 2011;10:391-6. [PMID: 21184285 DOI: 10.1007/s10689-010-9410-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
398 Svrcek M. [Case n(o) 6: Signet ring cell intramucosal carcinoma in hereditary diffuse gastric cancer with mutated CDH1 gene]. Ann Pathol 2011;31:381-4. [PMID: 21982246 DOI: 10.1016/j.annpat.2011.07.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
399 Mastoraki A, Danias N, Arkadopoulos N, Sakorafas G, Vasiliou P, Smyrniotis V. Prophylactic total gastrectomy for hereditary diffuse gastric cancer. Review of the literature. Surg Oncol. 2011;20:e223-e226. [PMID: 21872467 DOI: 10.1016/j.suronc.2011.08.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
400 Vasas P, Bijendra P. [Genetic background and clinical features of the hereditary diffuse gastric cancer]. Orv Hetil. 2011;152:1105-1109. [PMID: 21737393 DOI: 10.1556/OH.2011.29160] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
401 Shah MA, Salo-Mullen E, Stadler Z, Ruggeri JM, Mirander M, Pristyazhnyuk Y, Zhang L. De novo CDH1 mutation in a family presenting with early-onset diffuse gastric cancer. Clin Genet. 2012;82:283-287. [PMID: 21696387 DOI: 10.1111/j.1399-0004.2011.01744.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
402 Lynch HT, Aldoss I, Lynch JF. The identification and management of hereditary diffuse gastric cancer in a large Jordanian family. Familial Cancer 2011;10:667-72. [DOI: 10.1007/s10689-011-9463-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
403 Rizzo D, Arlotta A, Maurizi P, Ruggiero A, Attinà G, Riccardi R. Gastric adenocarcinoma presenting as thrombotic microangiopathy in a 14-year-old girl. J Pediatr Hematol Oncol 2011;33:e213-5. [PMID: 21623234 DOI: 10.1097/MPH.0b013e3182193239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
404 Jakubowska A, Lawniczak M, Wojnarska B, Cybulski C, Huzarski T, Byrski T, Tołoczko-Grabarek A, Jaworska K, Durda K, Starzyńska T, Lubiński J. CDH1 gene mutations do not contribute in hereditary diffuse gastric cancer in Poland. Fam Cancer 2010;9:605-8. [PMID: 20842455 DOI: 10.1007/s10689-010-9381-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
405 Wilcox R, Perpich M, Noffsinger A, Posner MC, Cooper K. Hereditary diffuse gastric cancer: multidisciplinary case report with review of the literature. Patholog Res Int 2011;2011:845821. [PMID: 21331337 DOI: 10.4061/2011/845821] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
406 Milne AN, Offerhaus GJA, Carneiro F. Histopathology of familial and early-onset gastric cancer. Diagnostic Histopathology 2011;17:62-8. [DOI: 10.1016/j.mpdhp.2010.10.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
407 Xie ZM, Li LS, Laquet C, Penault-Llorca F, Uhrhammer N, Xie XM, Bignon YJ. Germline mutations of the E-cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancer. Cancer. 2011;117:3112-3117. [PMID: 21271559 DOI: 10.1002/cncr.25876] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 4.5] [Reference Citation Analysis]
408 Li S, Yakar S, Brodt P. Role of the IGF-Axis in Liver Metastasis: Experimental and Clinical Evidence. Liver Metastasis: Biology and Clinical Management 2011. [DOI: 10.1007/978-94-007-0292-9_9] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
409 Corso G, Pedrazzani C, Pinheiro H, Fernandes E, Marrelli D, Rinnovati A, Pascale V, Seruca R, Oliveira C, Roviello F. E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer. Eur J Cancer. 2011;47:631-639. [PMID: 21106365 DOI: 10.1016/j.ejca.2010.10.011] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 4.3] [Reference Citation Analysis]
410 Raphael MF, Kluijt I, Koot BG, Smets AM, Tilanus ME, Bras J, van de Wetering MD. Gastric adenocarcinoma in a 13-year-old boy: a diagnosis not often seen in this age group. Pediatr Hematol Oncol 2011;28:71-7. [PMID: 21083354 DOI: 10.3109/08880018.2010.520820] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
411 Becker K, Keller G. Gastric Cancer. eLS 2010. [DOI: 10.1002/9780470015902.a0006056.pub2] [Reference Citation Analysis]
412 Wolf E, Geigl J, Svrcek M, Vieth M, Langner C. Hereditäres Magenkarzinom. Pathologe 2010;31:423-9. [DOI: 10.1007/s00292-010-1353-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
413 Carneiro F, Oliveira C, Seruca R. Pathology and genetics of familial gastric cancer. Int J Surg Pathol. 2010;18:33S-36S. [PMID: 20484258 DOI: 10.1177/1066896910366463] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
414 Brundler M, Borralho P, Karikoski R, Domizio P, Cohen MC. Gastrointestinal tract. Essentials of Surgical Pediatric Pathology 2000. [DOI: 10.1017/cbo9781139237000.004] [Reference Citation Analysis]
415 [DOI: 10.1101/2020.06.01.20118471] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]